2025 Annual Meeting | P12 - Poster Session 12

Date Wednesday 04/09/25

Time 11:45 AM - 12:45 PM PDT Add To Calendar

Location San Diego Convention Center | Exhibit Hall A

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) General Neurology, Cerebrovascular Disease and Interventional Neurology, Headache, Movement Disorders, Neuro-oncology, Sleep, Epilepsy/Clinical Neurophysiology (EEG), Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Infectious Disease, ��ɫ��, Research, and Methodology, Autoimmune Neurology, Neuro Trauma and Critical Care

Learning Objectives View the latest research on a variety of topics. Posters are available to view in-person or online.

CME Available 0.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Interactive

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM PDT	Abstract	1-001 - Lymphocyte Reconstitution Patterns in People with MS Being Treated with Rituximab After Alemtuzumab to Reduce the Frequency of Autoimmune Adverse Events in the RAMBLE Trial Sofia Jimenez Sanchez, PhD Student
11:45 AM - 12:45 PM PDT	Abstract	1-002 - Intermittent Calorie Restriction for Relapsing-remitting Multiple Sclerosis- A Systematic Review and Meta-analysis Felipe A. Gouhie
11:45 AM - 12:45 PM PDT	Abstract	1-003 - Remibrutinib Exposure in Cerebrospinal Fluid: Insights from a Study in Healthy Participants Bernd C. Kieseier, MD
11:45 AM - 12:45 PM PDT	Abstract	1-004 - The Impact of Gut Microbiota Modulation on Disease Progression and Symptom Management in Multiple Sclerosis Omar Anani
11:45 AM - 12:45 PM PDT	Abstract	1-005 - Comparative Effectiveness of Rituximab Versus Ocrelizumab Using Real-world Evidence: A Canadian Propensity-score Matched Observational Study Nathan Chu, MD
11:45 AM - 12:45 PM PDT	Abstract	1-006 - Adherence to Dimethyl Fumarate in Treatment-naive and Therapy-switched Individuals with Multiple Sclerosis: A Comparative Study Batuhan Ayci, MD
11:45 AM - 12:45 PM PDT	Abstract	1-007 - Mode of Delivery on Postpartum Well-being for Women with Multiple Sclerosis Tiffany Cao, Medical Student
11:45 AM - 12:45 PM PDT	Abstract	1-008 - Concurrent Multiple Sclerosis and Primary Sclerosing Cholangitis Treated with Oral Cladribine Carlos Guevara Oliva, MD
11:45 AM - 12:45 PM PDT	Abstract	1-009 - Extended Follow Up Data on the Efficacy and Safety of Cladribine for Multiple Sclerosis in a Greater London Hospital Miriam Mattoscio, MD, PhD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	1-010 - Anhedonia Underlies Executive Dysfunction in Persons with Multiple Sclerosis Emily Dvorak
11:45 AM - 12:45 PM PDT	Abstract	1-011 - Prevalence of and Risk Factors for Clinical Insomnia in Patients with Multiple Sclerosis John Dempsey, BA
11:45 AM - 12:45 PM PDT	Abstract	1-012 - 10 Hz tACS Promotes Myelin Repair and Improves Spatial Memory Following Cuprizone-induced Demyelination Thomas Scheinok, MD
11:45 AM - 12:45 PM PDT	Abstract	1-013 - Fatigue in Multiple Sclerosis: Time for a Patient-centered Approach to Evaluation and Treatment Raissa Aoun, MD
11:45 AM - 12:45 PM PDT	Abstract	1-014 - Tremor and Disability Outcomes After Deep Brain Stimulation for Multiple Sclerosis-associated Tremor Samantha Banks, MD
11:45 AM - 12:45 PM PDT	Abstract	1-015 - A Functional Electrical Stimulation Sleeve Improves Gait in Adults with MS: Application of Automated Gait Assessment Shane Poole
11:45 AM - 12:45 PM PDT	Abstract	1-016 - Trigeminal Neuralgia in Multiple Sclerosis: Characteristics and Healthcare Utilization in the State of Florida Freddy Escobar-Montealegre, MD
11:45 AM - 12:45 PM PDT	Abstract	1-017 - Psychological and Sexual Health in MS Patients: Findings from an Algerian Cohort Wail Abdelhamid Amroune, MD
11:45 AM - 12:45 PM PDT	Abstract	2-003 - Feasibility of Remotely Assessing Cognitive Function in Cardiac Surgery Patients Sydni Paleczny, MSc
11:45 AM - 12:45 PM PDT	Abstract	2-004 - Efficacy and Safety of Low-Sodium Oxybate in Narcolepsy Patients With/Without Psychiatric/Neurologic Comorbidities Thomas Measey
11:45 AM - 12:45 PM PDT	Abstract	2-005 - Cerebellar Syndrome and Parkinsonism Associated with Acquired Hepatocerebral Degeneration with Unusual Findings on Neuroimaging. Rodrigo Sanjinez, Sr., MD
11:45 AM - 12:45 PM PDT	Abstract	2-006 - Comparison Between Left and Right Hemisphere DTI-ALPS Indices and Associated Measurements in Healthy Subjects Hsiangkuo Yuan, MD, PhD
11:45 AM - 12:45 PM PDT	Abstract	2-007 - Artifacts and Safety of Oral Metals in Subjects Undergoing High-field Strength Brain Magnetic Resonance Imaging Celine S. Dumitrascu, Student
11:45 AM - 12:45 PM PDT	Abstract	2-008 - Neuropsychologic Profile of Neuro-PASC Patients Using the DCQ: A Cross-Sectional Study Josiane Stadler
11:45 AM - 12:45 PM PDT	Abstract	2-009 - Serotonin Syndrome Induced by the Pharmacological Interaction of Withania Somnifera and Escitalopram: A Case Report Fiona M. Hanly-Jorda
11:45 AM - 12:45 PM PDT	Abstract	2-010 - Patient-Reported Symptoms of Importance for Individuals with Mitochondrial Disease Christina Shupe
11:45 AM - 12:45 PM PDT	Abstract	2-011 - Clinical Characteristics and Risk Factors Associated with Seizures in Neuropsychiatric Systemic Lupus Erythematosus Andrea Nuñez de Caceres Garcia, MD
11:45 AM - 12:45 PM PDT	Abstract	2-012 - The Impact of an Integrated Outpatient Specialty Neurology Pharmacist in a Non-MS Clinical Setting Kayla Johnson, PharmD
11:45 AM - 12:45 PM PDT	Abstract	3-001 - Cerebellar ARIA in a Patient With an APP Duplication Treated With Lecanemab Darren R. Gitelman, MD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	3-002 - Safety and Efficacy of Monoclonal Anti-Tau Antibody in the Treatment of Alzheimer’s Disease Antonio Mutarelli
11:45 AM - 12:45 PM PDT	Abstract	3-003 - INTERCEPT-AD Biomarker Results: Early Effect of Sabirnetug Treatment on Synaptic Biomarkers in Alzheimer's Disease Elizabeth A. Johnson, PhD
11:45 AM - 12:45 PM PDT	Abstract	3-005 - Intracerebroventricular Injection of Autologous Adipose-Derived Stem Cells for the Treatment of Alzheimer’s Disease: Experience with the First of Three, 3-patient Cohorts in a “First-in-Human” Phase 1 FDA Trial Christopher M. Duma II, MD
11:45 AM - 12:45 PM PDT	Abstract	3-006 - Barriers and Solutions for Initiating Monoclonal Antibody Therapy in Alzheimer’s Disease Jeffrey B. Gelblum, MD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	3-007 - A Semi-Automated Tracking System for Monitoring Treatment with Novel Anti-amyloid Therapies Daniel W. Saukkonen
11:45 AM - 12:45 PM PDT	Abstract	3-008 - Lecanemab in Clinical Practice: Real-World Treatment Outcomes from a Retrospective Neurological Clinic Case Series Review in Early Alzheimer’s Disease Justin S. Moon, MD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	3-010 - Physiological ß-Amyloid Clearance by the Liver and Its Therapeutic Potential for Alzheimer’s Disease Yuan Cheng, PhD
11:45 AM - 12:45 PM PDT	Abstract	3-011 - Atypical Antipsychotics for Neuropsychiatric Symptoms in Alzheimer’s Disease: A Systematic Review and Meta-Analysis Letícia F. Saldanha, MS
11:45 AM - 12:45 PM PDT	Abstract	3-012 - Real-World Experience with Long-term Lecanemab Treatment: A Retrospective Chart Review in Early Alzheimer’s Disease David C. Weisman, MD
11:45 AM - 12:45 PM PDT	Abstract	3-013 - Novel Approach to Optimization of Alzheimer’s Vaccine Configuration for Maximal Targeting of Toxic Amyloid-Beta Oligomers Johanne M. Kaplan, PhD
11:45 AM - 12:45 PM PDT	Abstract	3-014 - Effect of Probiotics on Oxidative, Cognitive and Metabolic Outcomes in Alzheimer’s Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials Jamir Pitton Rissardo, MD
11:45 AM - 12:45 PM PDT	Abstract	3-016 - Dual Inhibition of Amyloid Aggregation: A Promising Therapeutic Strategy for Alzheimer's Disease in the Context of Type 2 Diabetes Mellitus Priyadharshine Ramesh Babu
11:45 AM - 12:45 PM PDT	Abstract	3-017 - Investigating the Effects of Semaglutide in Early Alzheimer’s Disease Using Single-cell Transcriptomics and Proteomics – Rationale and Design Grant T. Corbett, PhD
11:45 AM - 12:45 PM PDT	Abstract	3-018 - Comparison of Eligibility Criteria and Baseline Characteristics Between the Patient Populations of evoke and evoke+, Clarity AD and TRAILBLAZER-ALZ-2 Paul Mystkowski, MD
11:45 AM - 12:45 PM PDT	Abstract	3-019 - Lecanemab Treatment in Real World Settings in the United States Marwan N. Sabbagh, MD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	3-020 - Virtual Reality for Patients with Mild Cognitive Impairment: a Systematic Review and Meta-Analysis Julia Mello, Student
11:45 AM - 12:45 PM PDT	Abstract	4-001 - Establishing Psychometric Evidence of the Novel Patient-reported Functional Impacts of Narcolepsy Instrument (FINI) Using Data from Observational and Phase 2 Clinical Trials in Narcolepsy heather romero, PhD
11:45 AM - 12:45 PM PDT	Abstract	4-002 - Efficacy and Safety of TAK-861, an Oral Orexin Receptor 2 Agonist, in Individuals with Narcolepsy Type 1: Results from a Phase 2 Trial and Long-Term Extension Study Interim Analysis Ellie Stukalin, PhD
11:45 AM - 12:45 PM PDT	Abstract	4-003 - A Meta-analysis of Quantitative Electroencephalography (EEG) in Insomnia Sleep Disorder Unaiza Memon
11:45 AM - 12:45 PM PDT	Abstract	4-004 - Prevalence of Stroke in Insomniacs and Insomnia Evaluation Differences: A Tertiary Center Perspective. Emily R. Fisher, MD
11:45 AM - 12:45 PM PDT	Abstract	4-005 - Efficacy of Internet-based Cognitive Behavioral Therapy (ICBT) for Improving Sleep in Insomnia Patients- A Meta-analysis Sarika Mutyala, MBBS
11:45 AM - 12:45 PM PDT	Abstract	4-006 - Efficacy and Safety of Lemborexant Versus Placebo in Treating Adults with Insomnia Disorder: A Systematic Review and Meta-Analysis of 1,976 Patients Mohamed Alsaied
11:45 AM - 12:45 PM PDT	Abstract	4-007 - Impact of Circadian Rhythm Disruption on the Emotional and Psychological Well-being of Healthcare Personnel in Night Shifts: A Multicentric Study Ronald Hernandez
11:45 AM - 12:45 PM PDT	Abstract	5-001 - Designing and Implementing a Neurology Trainee Mentorship Curriculum Brittany Russo, MD
11:45 AM - 12:45 PM PDT	Abstract	5-003 - Virtual Recruitment: A Single Center Experience of Virtual Neurology Residency Interviews Ankush Maheshwary, MBBS
11:45 AM - 12:45 PM PDT	Abstract	5-004 - Confidence of Medical Residents in the Neurological Exam Alexa Keeling, MD, MSc
11:45 AM - 12:45 PM PDT	Abstract	5-005 - Transition to Night Float: The Impact on Resident Quality of Life, ��ɫ��, and Patient Care Sukriye Damla Kara, MD
11:45 AM - 12:45 PM PDT	Abstract	5-006 - Code Hemorrhage: A Multidisciplinary Approach to Improving Outcomes for Spontaneous Intracranial Hemorrhage Micah Sy, MD
11:45 AM - 12:45 PM PDT	Abstract	5-007 - Interactive ��ɫ��al Workshop Improves Neurology Resident Knowledge on Multiple Sclerosis Irena Dujmovic Basuroski, MD, PhD
11:45 AM - 12:45 PM PDT	Abstract	5-009 - NeurAnki: Behind The Scenes of Creating the First-Ever Flashcard Based Deck for Resident ��ɫ�� Idha Sood
11:45 AM - 12:45 PM PDT	Abstract	5-010 - Optimizing Transitions 2.0: Feedback-Driven Revisions to a Neurology Bootcamp to Enhance Resident Competence Through a Milestone-driven Curriculum Adnan Husein, MD
11:45 AM - 12:45 PM PDT	Abstract	5-011 - Closing the Care Divide in Rett Syndrome: Connecting Centers of Excellence With Community Clinicians Through a Multidisciplinary, Multiphase, Geotargeted ��ɫ��al Initiative Carole Drexel
11:45 AM - 12:45 PM PDT	Abstract	5-012 - Parkinson’s Disease in Primary Care: A One-Day ��ɫ��al Training Intervention Designed for General Practitioners and Pharmacists Manon Auffret, PhD, PharmD, DAAN
11:45 AM - 12:45 PM PDT	Abstract	5-013 - Feasibility and Efficacy of an Interactive Neurological Emergencies Curriculum for First Responders – A Pilot Study Tamia Garrett, MS
11:45 AM - 12:45 PM PDT	Abstract	5-014 - Educating Our Internal Medicine Colleagues: Preliminary Results from an Ongoing Near-Peer Stroke ��ɫ�� Initiative Lauren Nelson, MD
11:45 AM - 12:45 PM PDT	Abstract	5-015 - Closing Gaps: A qualitative analysis of participanClosing Gaps: A Qualitative Analysis of Participants’ Self-Reported ��ɫ��al Gains and Outcomes After an International E-Learning Course in Neuropalliative Carets’ self-reported educational gains and outcomes after an international e-learning course in neuropalliative care Neha M. Kramer, MD
11:45 AM - 12:45 PM PDT	Abstract	5-016 - Study of Onboarding for Neurology APPs (SONAr): Lessons Learned from the 1-year Interim Data Analysis Daniel S. Harrison, MD
11:45 AM - 12:45 PM PDT	Abstract	5-018 - ��ɫ��al Value of Electronic Consults (E-consults) in a Neurology Resident Clinic at a Large Safety-net Hospital Vaishnavi Aryapadi, MD
11:45 AM - 12:45 PM PDT	Abstract	5-019 - Implementation and Pilot Evaluation of NeuEJM: the Neurology Medical ��ɫ�� Journal Club Galina Gheihman, MD
11:45 AM - 12:45 PM PDT	Abstract	5-020 - Needles in Haystacks: A Cross-Sectional Study of Community-Engaged Research in High-Impact General Neurology Journals Sydney Bitting
11:45 AM - 12:45 PM PDT	Abstract	5-021 - Are We Conducting High-Impact Research? A Comparison Between Neurological Research Output and the Global Burden of Disease Andrés F. Patiño-Aldana, MD, MSc
11:45 AM - 12:45 PM PDT	Abstract	5-022 - Leading the Way in Medical Student Exploration of Neurology: How Neurology SIGNposts Promotes Diversity throughout the Pipeline Nara Michaelson, MD
11:45 AM - 12:45 PM PDT	Abstract	5-023 - Exploring the Potential of Fundus Cameras in Neurological Ward Assessments: A Pilot Study Bruna Leles Vieira de Souza, MD
11:45 AM - 12:45 PM PDT	Abstract	5-024 - The Neurology Digital ��ɫ�� Scholars Program: Year One Outcomes Jessica H. Goldstein, MD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	5-025 - Developing Transformative Technologies to Enhance Equitable Acute Stroke Care in Patients with Limited English Proficiency Bavica Gummadi, DO
11:45 AM - 12:45 PM PDT	Abstract	5-026 - Making Computer-Generated Animated Videos to Illustrate the Neurological Examination Emily Unebasami
11:45 AM - 12:45 PM PDT	Abstract	5-027 - Large Language Model-Supported Interactive Case-Based Learning: A Pilot Study Stephen Bacchi, MBBS
11:45 AM - 12:00 PM PDT	Abstract	5-028 - Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA) Michele Potashman, PhD
11:45 AM - 12:00 PM PDT	Abstract	5-029 - Mechanisms of REV1-dependent Trinucleotide Repeat Instability Ava Siegel
11:45 AM - 12:00 PM PDT	Abstract	5-030 - Auto-brewery Syndrome Presenting with Recurrent Episodes of Reduced Level of Consciousness, Confusion, and Ataxia Julius B. Anang, MD, FAAN
11:45 AM - 12:00 PM PDT	Abstract	5-031 - Timing and Frequency of Onset Symptoms in Friedreich Ataxia Based on Real-world Medical Claims Data Jim McKay, PhD
11:45 AM - 12:00 PM PDT	Abstract	5-032 - Progression of Friedreich Ataxia to Scoliosis and Cardiomyopathy: Utility of Real-World Data From Medical Claims Jim McKay, PhD
11:45 AM - 12:45 PM PDT	Abstract	6-001 - Endothelial Activation as a Predictor of Mortality in CD19-Directed CAR-T Therapy Jose Maria Cabrera Maqueda
11:45 AM - 12:45 PM PDT	Abstract	6-002 - ICCAN-CNS: Update on Patient Navigation and Essential Needs Program for Patients with CNS Tumors Joshua A. Budhu, MD
11:45 AM - 12:45 PM PDT	Abstract	6-003 - Autologous Hemopoietic Stem Cell Transplantation for Paraneoplastic Cerebellar Degeneration Jose Maria Cabrera Maqueda
11:45 AM - 12:45 PM PDT	Abstract	6-004 - A Retrospective Study of Subtle and Chronic Neurological Findings from CART in an Ethnically Diverse, Real-world Cohort Samantha J. Cheng, MD
11:45 AM - 12:45 PM PDT	Abstract	6-006 - Anti-Hu Paraneoplastic Syndrome in a Patient with Rhabdomyosarcoma Mariam Tadross
11:45 AM - 12:45 PM PDT	Abstract	6-007 - Cranial Neuropathies as Adverse Events from Immune Checkpoint Inhibitors Catherine Garcia, MD
11:45 AM - 12:45 PM PDT	Abstract	6-008 - An Updated Evaluation of Multiple Sclerosis Outcomes After Immune Checkpoint Inhibitors from the FAERS Database Catherine Garcia, MD
11:45 AM - 12:45 PM PDT	Abstract	6-009 - Chimeric Antigen Receptor-T Cell Mediated Bilateral Facial Nerve Palsy Jashank A. Parwani, MBBS
11:45 AM - 12:45 PM PDT	Abstract	6-010 - Neurotoxicity and Neurological Events in CAR-T Cell Therapy: A Meta-analysis of Randomized Clinical Trials Frederico M. de Sousa Marinho Mendes Filho
11:45 AM - 12:45 PM PDT	Abstract	6-011 - Limbic Encephalitis, Myelitis, and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Associated with Anti-Ma2 Antibody Paraneoplastic Neurologic Syndrome (PNS) in a Patient with Germ Cell Testicular Tumor: A Case Report Lemuel Hope S. Galindo
11:45 AM - 12:45 PM PDT	Abstract	6-012 - Encephalopathy as Initial Presentation of Hemophagocytic Lymphohistiocytosis Luiz Henrique Medeiros Geraldo, MD, PhD
11:45 AM - 12:45 PM PDT	Abstract	6-013 - Immune Checkpoint Inhibitor-induced Encephalitis: Pembrolizumab Triggering Seizures, Aphasia, and Personality Change Stella Adetokunbo, MD
11:45 AM - 12:45 PM PDT	Abstract	6-014 - Glioblastoma Multiforme Tumor Volume and Persistence of Chimeric Antigen Receptor T Cells Following Neurosurgical Debulking Devi Veerappan
11:45 AM - 12:45 PM PDT	Abstract	6-015 - Correlation Analysis of Lymphocyte and CD 4 Counts in Glioblastoma: Insight into Immunosuppression and Pneumocystis jiroveci pneumonia (PJP) Prophylaxis in Viral Gene Therapy and Standard of Care (SOC) – A Single Center Study Jorge Akira Valdivia Moriyama, MD
11:45 AM - 12:45 PM PDT	Abstract	6-016 - Co-occurrence of multiple sclerosis and Hodgkin lymphoma. Is there a common pathophysiology? Yugant Khand, MBBS, DiMM
11:45 AM - 12:45 PM PDT	Abstract	6-017 - Effectiveness of CAR T-cell Therapy in Improving Overall Survival in Patients with Glioblastoma Multiforme Compared to Conventional Chemotherapy: A Systematic Review Yahir A. Chico-Alcaraz, MD
11:45 AM - 12:45 PM PDT	Abstract	6-018 - A High-grade Glioma Mimicking Tumefactive Multiple Sclerosis Steven J. Roman Troche, MD
11:45 AM - 12:45 PM PDT	Abstract	6-020 - A Case of Primary Central Nervous System B-cell Lymphoma Resembling Autoimmune Encephalitis Joyce A. Jimenez Zambrano, MD
11:45 AM - 12:45 PM PDT	Abstract	7-001 - Neurocritical Complications of Basal Cell Carcinoma with Intracranial Invasion Rachael Wittmer
11:45 AM - 12:45 PM PDT	Abstract	7-002 - Do Medical Miracles Exist? A Systematic Review of Unanticipated Recovery from Coma as Portrayed in the Media Alexander T. Scott, Research coordinator
11:45 AM - 12:45 PM PDT	Abstract	7-003 - Reversible Coma from Intrathecal Baclofen Toxicity Mahrin Rahman, DO
11:45 AM - 12:45 PM PDT	Abstract	7-004 - Glyburide in the Treatment of Cerebral Edema: A Systematic Review and Meta-analysis Giovanna Salema Pascual
11:45 AM - 12:45 PM PDT	Abstract	7-005 - Human Herpes Virus 6 (HHV-6) Encephalitis Presenting as New Onset Refractory Status Epilepticus in an Immunocompetent Adult Shelby Freeman, MD
11:45 AM - 12:45 PM PDT	Abstract	7-006 - A Multimodal Analysis of Visual Impairments, Visual Evoked Potentials, and Cerebral Metabolism in Patients with Severe Brain Injury Atakan Selte, MD
11:45 AM - 12:45 PM PDT	Abstract	7-007 - Diagnosis of Electrographic Status Epilepticus by an Automated Seizure-burden Monitoring Algorithm and Its Association with Outcomes at Discharge Aaron F. Struck, MD
11:45 AM - 12:45 PM PDT	Abstract	7-008 - Predictive Value of Early Quantitative EEG Features in Critically Ill Moderate-severe Traumatic Brain Injury (TBI) Patient Prognostication Kotaro Tsutsumi, MD
11:45 AM - 12:45 PM PDT	Abstract	7-009 - Identifying Barriers to Providing Emergent Neurologic Life Support in Low- and Middle-income Sub-Saharan African Countries Celia Fung, MD
11:45 AM - 12:45 PM PDT	Abstract	7-010 - Atypical Non-fatal High-altitude Cerebral Edema (HACE) with Complete Corpus Callosum Involvement– A Unique Case Report Mitali Chansarkar, MD
11:45 AM - 12:45 PM PDT	Abstract	8-001 - Frequency of Seroconversion in Aquaporin-4 Antibody Testing: Insights from Real-World Data Tatchaporn Ongphichetmetha
11:45 AM - 12:45 PM PDT	Abstract	8-003 - Preference for Inebilizumab Home Infusion Among People with Neuromyelitis Optica Spectrum Disorder Gerome B. Vallejos, MD
11:45 AM - 12:45 PM PDT	Abstract	8-004 - Potential Correlation Between the Cuprotosis-Related Genes and Acute-Remitting Course in Neuromyelitis Optica Spectrum Disorder Peidong Liu
11:45 AM - 12:45 PM PDT	Abstract	8-005 - Prevalence and Clinical Significance of Anti-MOG in the Cerebrospinal Fluid of Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Systematic Review with Meta-Analysis Gerardo M. Luna-Peralta
11:45 AM - 12:45 PM PDT	Abstract	8-006 - Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in a patient with Sjogren's Syndrome: A Case Report and Literature Review Mattia Wruble, MD
11:45 AM - 12:45 PM PDT	Abstract	8-007 - 21 Years From Onset to Second Attack in a Case of MOGAD Sean Montgomery, MD
11:45 AM - 12:45 PM PDT	Abstract	8-009 - Treatment Options for NMOSD in Children: Effectiveness and Safety of Subcutaneous Tocilizumab Alejandra Duque Ramirez, MD
11:45 AM - 12:45 PM PDT	Abstract	8-010 - Successful Inebilizumab Treatment in Aquaporin-4 Immunoglobulin G Seropositive Neuromyelitis Optica Spectrum Disorder Patient with Hepatitis C Virus Infection: A Case Report Sha Jing
11:45 AM - 12:45 PM PDT	Abstract	8-011 - Neuromyeltis Optica Spectrum Disorder Disease Activity in the Nonagenarians: Recalcitrant Autoimmunity Unabated by Aging Melissa Bendayan, MD
11:45 AM - 12:45 PM PDT	Abstract	8-012 - Inebilizumab Treatment in a Patient with Co-occurring AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis: A Case Report and Literature Review Xiaoqian Song
11:45 AM - 12:45 PM PDT	Abstract	8-013 - Effect of Inebilizumab on Alleviating the Neuromyelitis Optica Spectrum Disorder Related Neuropathic Pain: Cases Report Hongxuan Wang
11:45 AM - 12:45 PM PDT	Abstract	8-014 - Pharmacological Interventions for Symptomatic Management of Neuromyelitis Optica Spectrum Disorder (NMOSD) : A Network Meta-analysis of Randomised Controlled Trials Malavika Rudrakumar
11:45 AM - 12:45 PM PDT	Abstract	9-001 - Treatment of Prolonged Seizure With Diazepam Nasal Spray: A Post Hoc Cohort Analysis Steven T. Whitworth, PhD
11:45 AM - 12:45 PM PDT	Abstract	9-002 - Real-World Use of Fenfluramine for Dravet Syndrome: a Retrospective Cohort Study Using a National Pharmacy Database Wesley Kerr, MD, PhD
11:45 AM - 12:45 PM PDT	Abstract	9-003 - Wide Range of Cenobamate Doses Associated With Initial Seizure Freedom in Patients With Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study William E. Rosenfeld, MD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	9-004 - Exploring Proposed Recommendations for Acute Cluster Treatment and Rapid and Early Seizure Termination Using Data From a Long-Term Safety Study of Diazepam Nasal Spray Steven T. Whitworth, PhD
11:45 AM - 12:45 PM PDT	Abstract	9-005 - Dosing Patterns and Persistence on Cannabidiol (CBD) – Insights From US Specialty Pharmacy Data Timothy B. Saurer, PhD
11:45 AM - 12:45 PM PDT	Abstract	9-006 - Corticotherapy Versus Adrenocorticotrophic Hormone for the Treatment of West Syndrome: a Systematic Review and Meta-analysis Aishwarya Koppanatham, MBBS
11:45 AM - 12:45 PM PDT	Abstract	9-007 - The Safety and Efficacy of Adjunctive Lacosamide for Partial-onset Seizures; a Meta-Analysis Faizan Shahzad
11:45 AM - 12:45 PM PDT	Abstract	9-009 - Evolving Trends in Antiseizure Medication Use: The Emerging Role of Lacosamide in Status Epilepticus Management—A Single-Center Retrospective Study Hassan Imtiaz, MD
11:45 AM - 12:45 PM PDT	Abstract	9-010 - Seizure Control in Epilepsy Patients Requiring Calcineurin Inhibitors: A Retrospective Review Ryan Nguyen, MD
11:45 AM - 12:45 PM PDT	Abstract	9-012 - Trends in Epilepsy Related Mortality from 1999-2020: An Analysis of the CDC Wonder Database Mohammad Ammar Ur Rahman, MBBS
11:45 AM - 12:45 PM PDT	Abstract	9-013 - Demographic Trends in Status Epilepticus-Related Morality in Older Adults in the United States (1999-2020): A Nationwide Retrospective Analysis Ana Leticia Fornari Caprara, MD
11:45 AM - 12:45 PM PDT	Abstract	9-017 - Brivaracetam Monotherapy Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization Among Patients With Epilepsy: A Cohort Study Using US Claims Data Brian D. Moseley, MD
11:45 AM - 12:45 PM PDT	Abstract	10-001 - Elevated Risk of Multiple Sclerosis and Related Outcomes in Epstein-Barr Virus-Positive Infectious Mononucleosis: A Population-Based Cohort Study John Diaz-Decaro, PhD, MS
11:45 AM - 12:45 PM PDT	Abstract	10-002 - Metabolomic Profiles in Epstein-Barr Virus Associated Encephalitis Pei Shang, MD, PhD
11:45 AM - 12:45 PM PDT	Abstract	10-003 - Cytomegalovirus (CMV) Encephalitis Presenting with Ring-Enhancing Lesions in a Solid Organ-Transplant (SOT) Recipient Timothy Beutler, MD
11:45 AM - 12:45 PM PDT	Abstract	10-004 - Clinical Manifestation, Auxiliary Examination Features, and Prognosis of Visual Impairment Associated with Herpes Infection: A Cohort Study Lei Liu, MD, PhD
11:45 AM - 12:45 PM PDT	Abstract	10-005 - Varicella Zoster Virus Reactivation Meningitis in Pregnancy Michelle Troup, MD
11:45 AM - 12:45 PM PDT	Abstract	10-006 - Diagnostic Value of the 'Insular Knife-Cut' Sign in Suspected Herpes Simplex Virus Encephalitis Sofia Marini, MD
11:45 AM - 12:45 PM PDT	Abstract	10-007 - Bilateral Acute Retinal Necrosis Leading to HSV-1 Encephalitis After Steroid Administration Nicholas Liquigli, DO
11:45 AM - 12:45 PM PDT	Abstract	10-008 - Herpes Simplex Virus 2 Reactivation with Medullary Hematoma and Elsberg Syndrome in a Young, Immunocompromised Adult Female Patrick Callaghan, MD
11:45 AM - 12:45 PM PDT	Abstract	10-009 - Elsberg Syndrome Caused by Herpes Simplex Virus Type 2 - A Case Report Alyssa R. Redai, MD
11:45 AM - 12:45 PM PDT	Abstract	11-001 - Post-onset ALSFRS-R Slope (POS) as a Predictor of Disease Progression in Patients with Amyotrophic Lateral Sclerosis (ALS) Larisa Ibric, Medical student
11:45 AM - 12:45 PM PDT	Abstract	11-006 - Screening for Genetic Mutations in a Midwest ALS Clinic and Assessing Disease Trajectory in Patients with Motor Neuron Disease Syed Ahmed, DO
11:45 AM - 12:45 PM PDT	Abstract	11-007 - Longitudinal Natural History of Facial-lingual Oro-motor Muscle Strength Changes in Amyotrophic Lateral Sclerosis (ALS) Patients Benjamin R. Brooks, MD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	11-008 - Gold Coast Criteria Diagnostic Accuracy in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis Aishwarya Koppanatham, MBBS
11:45 AM - 12:45 PM PDT	Abstract	11-009 - Nerve Biopsy is More Sensitive Than Fat Aspirate or Skin Biopsy for Amyloid Tissue Diagnosis in Symptomatic ATTRv Peripheral Neuropathy Alex H. Panrudkevich
11:45 AM - 12:45 PM PDT	Abstract	11-010 - INSIGHT-MP: Interpretable Natural Language Processing System for Identification of Transthyretin Amyloidosis with Mixed Phenotype Using Machine Learning Akshay Arora, MS
11:45 AM - 12:45 PM PDT	Abstract	11-011 - Findings from the Canadian Registry for Amyloidosis Research: Neurological Manifestations Rami Massie, MD
11:45 AM - 12:45 PM PDT	Abstract	11-013 - RNAi-based Therapies for Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Meta-analysis of Randomized Clinical Trials Aishwarya Koppanatham, MBBS
11:45 AM - 12:45 PM PDT	Abstract	11-014 - A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin Amyloidosis Catherine Daley, MD
11:45 AM - 12:45 PM PDT	Abstract	11-015 - Triple Amyloidosis: AL, AA, and Wild-type ATTR in a Single Patient with Amyloid Myopathy Santiago Martinez Sosa, MBBS
11:45 AM - 12:45 PM PDT	Abstract	11-016 - Lead Poisoning mimicking Chronic Inflammatory Axonal Polyneuropathy Shireen M. Jacob, MBBS
11:45 AM - 12:45 PM PDT	Abstract	11-017 - Translating IGHMBP2 Variants with a CMT2S Patient-specific Organ-on-a-chip Model: Personalized Medicine ASO-based Therapeutic Rescue Sandra Smieszek
11:45 AM - 12:45 PM PDT	Abstract	11-018 - Case Study on ALS Reversal: An Integrative Medicine Approach to Sporadic Limb-Onset ALS Diana Noland, Registered Dietitian
11:45 AM - 12:45 PM PDT	Abstract	11-019 - Homozygous Deletions in AHNAK2 as an Unexpected Genetic Cause of Polyneuropathy Nicholas Mallett, MD
11:45 AM - 12:45 PM PDT	Abstract	11-020 - Blurred Lines in Neurology: ATP1A1 Variant Redefines CMT Spectrum Lamees Alhallaq, MD
11:45 AM - 12:45 PM PDT	Abstract	11-021 - Hereditary Motor Sensory Neuropathy: Case Report and Update Genetic Implications Rolando M. Cordoves-Feria, MD
11:45 AM - 12:45 PM PDT	Abstract	11-022 - CMT1B Presenting with Hemifacial Spasm and Multiple Cranial Nerve Enhancement Jessica Bloom, MD
11:45 AM - 12:45 PM PDT	Abstract	11-023 - Entire Sequence Deletion of PMP22 Presenting as a Length-dependent Peripheral Neuropathy Marissa Ilardi, MD
11:45 AM - 12:45 PM PDT	Abstract	11-024 - Charcot-Marie-Tooth Disease and Parkinsonism in a 50 Year Old Patient with FIG4 Mutation Andrew Sefain, MD
11:45 AM - 12:45 PM PDT	Abstract	11-025 - Evaluating the Genetic Subtypes and Phenotypic Features of Charcot-Marie-Tooth Disease in Türkiye Fatma Yesim Parman, MD
11:45 AM - 12:45 PM PDT	Abstract	11-026 - Motoneuron Involvement in CANVAS: A Case of ACAGG Expansions in a Guamanian Man Gabrielle Dufort, MD
11:45 AM - 12:45 PM PDT	Abstract	11-027 - Could Droxidopa Become the First Symptomatic Therapy for Charcot-Marie-Tooth Disease? A Case Series Juliana Stoilova, MD
11:45 AM - 12:45 PM PDT	Abstract	11-028 - Expanding the Clinical, Pathological, and Molecular Spectrum of HSPB8-Neuromuscular Disorder Brendan Putko, MD, MSc
11:45 AM - 12:45 PM PDT	Abstract	11-029 - Clinical and Genetic Profiles of Congenital Myasthenic Syndromes: A Single Tertiary Care Center Experience from Saudi Arabia Fahad S. Bahanan, MBBS
11:45 AM - 12:45 PM PDT	Abstract	11-030 - Evolving Patterns of Myasthenia Gravis and Other Myoneural Disorders Related Mortality from 1999-2020: An Analysis of CDC Wonder Database Mohammad Ammar Ur Rahman, MBBS
11:45 AM - 12:45 PM PDT	Abstract	11-031 - The Path to Diagnosis and Treatment Among Patients With Generalized Myasthenia Gravis (gMG): Health Disparities Experienced by Racial and Ethnic Minorities From Project ASPIRE (eliminAte diSparities and Promote equIty in Rare diseasE) Marla B. Morgan, MD
11:45 AM - 12:45 PM PDT	Abstract	11-032 - Clinical Outcomes and Events in a United States Generalized Myasthenia Gravis Population: Analysis of Real-world Data Lesley-Ann 9. Miller-Wilson, PhD
11:45 AM - 12:45 PM PDT	Abstract	11-033 - Assessing the Rate and Causes of Myasthenia Gravis Misdiagnosis Silvia Falso, MD
11:45 AM - 12:45 PM PDT	Abstract	11-034 - Evidence of Higher Incidence of Myasthenia Gravis During Summer Silvia Falso, MD
11:45 AM - 12:45 PM PDT	Abstract	12-001 - Sex Differences in Treatment Response and Patient Preference in Gepant Users: A Real-World Survey Study from a Tertiary Headache Center Hsiangkuo Yuan, MD, PhD
11:45 AM - 12:45 PM PDT	Abstract	12-002 - Efficacy and Safety of Erenumab for Chronic Migraine and Medication Overuse: A Comprehensive Systematic Review and Single Arm Meta-Analysis Rebeca O. Silva, Student
11:45 AM - 12:45 PM PDT	Abstract	12-003 - Long-term Reductions in Monthly Headache Days With Eptinezumab Treatment in Adults With Chronic Migraine: Results From the PREVAIL Study Neha Kapur
11:45 AM - 12:45 PM PDT	Abstract	12-004 - Impact of Atogepant on Daily Functioning in Patients with Episodic Migraine and Chronic Migraine: Activity Impairment in Migraine-Diary (AIM-D) Item-Level Analysis Rashmi B. Halker Singh, MD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	12-005 - Long-term Maintenance of =50% and =75% Migraine Response With Eptinezumab in Patients With High-frequency Episodic Migraine and Chronic Migraine and 2-4 Prior Migraine Preventive Treatment Failures Jessica Ailani, MD, FAAN
11:45 AM - 12:45 PM PDT	Abstract	12-006 - Progressive Modifications in Migraine Course Following Multiple Treatment Cycles with Anti-CGRP Monoclonal Antibodies: Findings from the Multicenter, Prospective I-GRAINE Study. Roberta Messina, MD, PhD
11:45 AM - 12:45 PM PDT	Abstract	12-007 - Long-Term Efficacy of Fremanezumab in Patients with Chronic Migraine: a Systematic Review and Single-Arm Meta-Analysis Murilo Cruccioli
11:45 AM - 12:45 PM PDT	Abstract	12-008 - Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Chronic Migraine with Medication Overuse: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Gabriela D. Carolino
11:45 AM - 12:45 PM PDT	Abstract	12-009 - Comparative Efficacy and Safety of Atogepant as Prophylaxis for Chronic and Episodic Migraine in Adults: a Systematic Review with Meta-Analysis and Trial Sequential Analysis Paweł Chochoł, MD
11:45 AM - 12:45 PM PDT	Abstract	12-010 - Patient-reported Impact of ≥75% Increase in Good Days/Month on Migraine Symptoms, Quality of Life, and Brain Fog: Real-world Study of Adults With Chronic Migraine Treated With Eptinezumab Charles E. Argoff, MD
11:45 AM - 12:45 PM PDT	Abstract	13-001 - The Combined Impact of Intravenous Thrombolysis and Transfer Strategy on Endovascular Thrombectomy Outcomes for Vertebrobasilar Artery Occlusions Lucas Rios Rocha, MD
11:45 AM - 12:45 PM PDT	Abstract	13-002 - Outcomes of Endovascular Thrombectomy for Stroke in Patients with Low NIHSS Scores: A Retrospective Cohort Study of 90,740 patients Ariel Sacknovitz, Medical Student
11:45 AM - 12:45 PM PDT	Abstract	13-003 - Safety and Efficacy of Intravenous Thrombolysis in Acute Ischemic Stroke (AIS) Patients Presenting Beyond 4.5 Hours or with Unknown Onset of Symptoms: A Systematic Review and Meta-Analysis Abyaz Asmar, MD
11:45 AM - 12:45 PM PDT	Abstract	13-004 - An Analysis Of Malpractice Litigation Related To Mechanical Thrombectomy For Acute Stroke Michael Chojnacki
11:45 AM - 12:45 PM PDT	Abstract	13-005 - Emergent Carotid Endarterectomy Is Associated with Good 3-month Clinical Outcomes and Low 3-month Mortality in Patients with Acute Ischemic Stroke and Acute Cervical Internal Carotid Artery Occlusion Roman Herzig, MD, PhD
11:45 AM - 12:45 PM PDT	Abstract	13-006 - Analysis of 20,000 Patients with Acute Ischemic Stroke treated with Endovascular Thrombectomy using Machine Learning Clustering Algorithm Ariel Sacknovitz, Medical Student
11:45 AM - 12:45 PM PDT	Abstract	13-007 - Impact of Code LVO Implementation Based on RACE Score: A Real-World Outcome Analysis Khushi Patel, MD
11:45 AM - 12:45 PM PDT	Abstract	13-008 - Effects of Tirofiban on Functional Outcomes in Patients with Acute Ischemic Stroke Ineligible for Reperfusion Therapy: A Systematic Review and Meta-Analysis of Randomized Studies Yuri G. de Souza
11:45 AM - 12:45 PM PDT	Abstract	13-009 - Intravenous Thrombolysis with Tenecteplase Versus Alteplase in Acute Ischemic Stroke Tandem Lesions: a Systematic Review and Meta-Analysis of Current Available Literature Ocilio R. Goncalves, MS
11:45 AM - 12:45 PM PDT	Abstract	13-010 - Thrombectomy Outcomes of Intracranial Atherosclerosis-Related Occlusions (ICAS) vs non-ICAS Occlusions: A Systematic Review and Meta-Analysis Abyaz Asmar, MD
11:45 AM - 12:45 PM PDT	Abstract	13-011 - Endovascular Treatment versus Medical Treatment for Basilar Artery Occlusion: A Systematic Review and Meta-Analysis Artur Menegaz de Almeida, MS
11:45 AM - 12:45 PM PDT	Abstract	13-013 - The Learning Effect on Door-to-Needle Time for Telemedicine-Administered Thrombolytics in Acute Ischemic Stroke: A Frequentist Analysis from a Rural Stroke Network in the Midwest. Amber Schwertman
11:45 AM - 12:45 PM PDT	Abstract	13-014 - The Effect of Intensive Medical and Endovascular Therapy vs Medical Therapy Alone on the Incidence of Stroke and Death in Patients with Symptomatic Intracranial Artery Stenosis: A Meta-Analysis of Randomized Clinical Trials Muhammad Sohaib, MBBS
11:45 AM - 12:45 PM PDT	Abstract	13-015 - Safety and Efficacy of Endovascular Embolization For Pediatric Arteriovenous Malformation: Systematic Review and Meta-Analysis Karlos A. Acurio, MD
11:45 AM - 12:45 PM PDT	Abstract	13-016 - Elevated Pre-hospital Blood Pressure is Associated with Reduced Infarct Volume in Large Vessel Occlusion Ischemic Strokes Milagros Galecio-Castillo, MD
11:45 AM - 12:45 PM PDT	Abstract	13-017 - Safety and Post-operative Complications of Endovascular Versus Surgical Versus Follow-up and Medical Treatment for Patients with Vertebrobasilar Artery Stenosis: Propensity Score Weighting and a Machine Learning Driven Analysis Sai Varun Bethina, MBBS
11:45 AM - 12:45 PM PDT	Abstract	13-018 - Optimizing Overall Management Times for Emergency Department Stroke Code Protocols - Lone Star Stroke Research Consortium Yohan Kim, DO
11:45 AM - 12:45 PM PDT	Abstract	13-019 - Impact of Intracranial Vessel Tortuosity on Mechanical Thrombectomy Outcomes in Acute Ischemic Stroke: A Systematic Review Mohamed Derhab, MD, MBBCH
11:45 AM - 12:45 PM PDT	Abstract	13-020 - Emboguard Balloon Guide Catheter in Stroke Thrombectomy: Procedural Insights and Outcomes Anmol Almast
11:45 AM - 12:45 PM PDT	Abstract	14-001 - Identifying Facilitators and Barriers to Positive Illness Perceptions in Younger Stroke Survivors during Acute Hospitalization Mary Craven
11:45 AM - 12:45 PM PDT	Abstract	14-002 - Racial Disparity in Stroke and Chronic Kidney Disease Mortality among Black Population in the United States Wanprapit Noree, MD
11:45 AM - 12:45 PM PDT	Abstract	14-003 - Association of Demographics and Socioeconomic Factors on Anxiety and Depression in Survivors of Aneurysmal Subarachnoid Hemorrhage Ariyaporn Haripottawekul
11:45 AM - 12:45 PM PDT	Abstract	14-004 - Intra-population Disparities in Alcohol Consumption and Associated Intracerebral Hemorrhage Risk in East India Vishal Mehta, MD
11:45 AM - 12:45 PM PDT	Abstract	14-005 - Mortality Predictors in Hispanic Populations with Anterior Circulation Ischemic Stroke Outside the Thrombolytic Window Danny J. Japon
11:45 AM - 12:45 PM PDT	Abstract	14-006 - Prevalence of Large Vessel Occlusion (LVO) in Latin American Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Niels V. Pacheco, MD
11:45 AM - 12:45 PM PDT	Abstract	14-007 - Impact of a Stroke Support Group Stroke ��ɫ�� Series in a Neurologically-Underserved Community Tamia Garrett, MS
11:45 AM - 12:45 PM PDT	Abstract	14-008 - Sociodemographic Determinants of Health and Hospital Arrival Times in Stroke Patients in Erie County, New York: Preliminary Data Aya A. Ouf, MBBS
11:45 AM - 12:45 PM PDT	Abstract	14-010 - Mortality Predictors in Hispanic Patients with Posterior Circulation Ischemic Stroke Outside the Thrombolytic Window: The Impact of Chief Complaints Carlos A. Rodríguez Alarcón, MD
11:45 AM - 12:45 PM PDT	Abstract	14-011 - Evaluating the Role of a Community Stroke ��ɫ�� Initiative for the Nashville Asian American and Pacific Islander Population Jieun Kang, MD
11:45 AM - 12:45 PM PDT	Abstract	14-012 - Resilience and Recovery: Exploring the Spectrum of Physical Wellbeing in Ischemic and Hemorrhagic Stroke Survivors Through Diverse Therapy Experiences Sofia Constantinescu, BS
11:45 AM - 12:45 PM PDT	Abstract	14-013 - Patient Engagement and Co-creation of Rare Disease Research: Lessons from the Global Moyamoya Patient Registry Michael Devlin
11:45 AM - 12:45 PM PDT	Abstract	14-014 - Lessons from a Patient Advisory Board: Barriers & Faciliators to Post-Stroke Blood Pressure Control Rachel Kitagawa
11:45 AM - 12:45 PM PDT	Abstract	14-015 - Standardized Inpatient Telestroke to Improve Access to Stroke Specialists Karen S. Stalin
11:45 AM - 12:45 PM PDT	Abstract	14-016 - Impact of Prehospital Stroke Severity Scale Acquisition on Treatment Times Among Non-Urban Patients Undergoing Mechanical Thrombectomy in a Large Healthcare System Abdullah M. Al-Qudah, MD

Faculty Disclosures
Sofia Jimenez Sanchez, PhD Student	Miss Jimenez Sanchez has received research support from Multiple Sclerosis Australia .
Simon Broadley, PhD, FRACP	The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Broadley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. The institution of Dr. Broadley has received research support from NHMRC. The institution of Dr. Broadley has received research support from ARC. The institution of Dr. Broadley has received research support from GCH Foundation. The institution of Dr. Broadley has received research support from NHMRC.
Sonya M. Marshall-Gradisnik, PhD	Prof. Marshall-Gradisnik has nothing to disclose.
Natalie Eaton-Fitch, PhD	Dr. Eaton-Fitch has nothing to disclose.
Jose Maria Cabrera Maqueda	Mr. Cabrera Maqueda has nothing to disclose.
Elianet Fonseca, MD	Dr. Fonseca has nothing to disclose.
Carlos Serra Smith, Sr., MD	Dr. Serra Smith has nothing to disclose.
Monica alaña, Sr., PhD	Mrs. alaña has nothing to disclose.
Francisco J. Hernandez-Chamorro, Sr., MD	Dr. Hernandez-Chamorro has nothing to disclose.
Gabriel Velilla-Alonso, MD	Mr. Velilla-Alonso has nothing to disclose.
Sara Gil-Perotin, Sr., MD, PhD	Dr. Gil-Perotin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Gil-Perotin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Gil-Perotin has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bristol Myers Squib. Dr. Gil-Perotin has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Lorena Martín-Aguilar, Jr., MD, PhD	Mrs. Martín-Aguilar has nothing to disclose.
Tamara Castillo-Trivino, MD, MAS, FAAN	Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Roser Velasco Fargas	Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Roser Velasco Fargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving as a Consultant for Seagen. Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. The institution of Roser Velasco Fargas has received research support from ISCIII.
Juan Luis Chico-García, MD	Mr. Chico-García has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Bristol-Myers Squib, Johnson&Johnson, Merck, Novartis. The institution of Mr. Chico-García has received research support from Bristol-Myers Squib. The institution of Mr. Chico-García has received research support from Sanofi. Mr. Chico-García has received intellectual property interests from a discovery or technology relating to health care.
Pablo Cabezudo-García, MD, PhD	Dr. Cabezudo-García has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Angelini. Dr. Cabezudo-García has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Cabezudo-García has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for EISAI. Dr. Cabezudo-García has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Jazz Pharma. The institution of Dr. Cabezudo-García has received research support from Junta de Andalucía. Neuro-Reca.
Cristina Izquierdo, PhD	Dr. Izquierdo has nothing to disclose.
PURIFICACION CACABELOS, MD, PhD	Dr. CACABELOS has nothing to disclose.
Ines Gonzalez Suarez	Ines Gonzalez Suarez has nothing to disclose.
Margarita Massot Cladera, MD	Mrs. Massot Cladera has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alter.
Jaime Gallego Perez De Lar	Jaime Gallego Perez De Lar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Jaime Gallego Perez De Lar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Jaime Gallego Perez De Lar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for j&J.
Estefania Garcia Molina	Estefania Garcia Molina has nothing to disclose.
gabriel torres iglesias, Sr., MD	Mr. torres iglesias has nothing to disclose.
Marta Dominguez Gallego, MD	Miss Dominguez Gallego has nothing to disclose.
Lucia A. Alcantara, MD	Miss Alcantara has nothing to disclose.
Victor Guerra-Fernandez, MD	Mr. Guerra-Fernandez has nothing to disclose.
María T. Alba Isasi, MD	Dr. Alba Isasi has nothing to disclose.
Nuria Martinez Cibrian, MD	Miss Martinez Cibrian has nothing to disclose.
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Eugenia Martinez-Hernandez, MD	Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. The institution of Dr. Martinez-Hernandez has received research support from Fundacio La Caixa. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria and attending meetings with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring.
Yolanda Blanco Morgado, MD	Dr. Blanco Morgado has nothing to disclose.
Helena Huhmar	Helena Huhmar has nothing to disclose.
Per Sjögren	Per Sjögren has nothing to disclose.
Bo Bertilson	The institution of Bo Bertilson has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medect Clinical AB.
Björn Bragée	Björn Bragée has nothing to disclose.
Lauri S. Soinne, MD, PhD, FAAN	Dr. Soinne has nothing to disclose.
Darren R. Gitelman, MD, FAAN	The institution of an immediate family member of Dr. Gitelman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra Zeneca. The institution of Dr. Gitelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Dr. Gitelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Gitelman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Gitelman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. An immediate family member of Dr. Gitelman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of an immediate family member of Dr. Gitelman has received research support from Pfizer. The institution of an immediate family member of Dr. Gitelman has received research support from UCB. The institution of Dr. Gitelman has received research support from Biogen. The institution of Dr. Gitelman has received research support from Eisai. The institution of Dr. Gitelman has received research support from Lilly. The institution of Dr. Gitelman has received research support from Cassava. The institution of Dr. Gitelman has received research support from Wake Forest / Alzheimer's Association / NIH. The institution of Dr. Gitelman has received research support from Davos Alzheimer's Collaborative. The institution of Dr. Gitelman has received research support from Bristol Myers Squibb.
Jorge J. Llibre Guerra, MD	Dr. Llibre Guerra has nothing to disclose.
Eric M. McDade, DO	Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche-Genentech. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Hoffman-La Roche. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Eisai. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer.
Lon Schneider, MD	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immue. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athira. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha-cognition. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortexyme. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Ltd. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Eli Lilly. The institution of Dr. Schneider has received research support from Biogen. The institution of Dr. Schneider has received research support from Biohaven.
Tammie Benzinger	Tammie Benzinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $0-$499 for serving as a Consultant for Sora Neuroscience. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol, Myers Squibb. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PeerView. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. The institution of Tammie Benzinger has received research support from Siemens. The institution of Tammie Benzinger has received research support from Hyperfine. Tammie Benzinger has a non-compensated relationship as a Consultant with Siemens that is relevant to AAN interests or activities. Tammie Benzinger has a non-compensated relationship as a Consultant with Eisai that is relevant to AAN interests or activities.
William C. Kreisl, MD	Dr. Kreisl has received personal compensation for serving as an employee of Eisai Inc. Dr. Kreisl has received personal compensation for serving as an employee of Apellis Pharmaceuticals. An immediate family member of Dr. Kreisl has received personal compensation for serving as an employee of Novartis. Dr. Kreisl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enigma.
Randall Bateman, MD	Dr. Bateman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for C2N Diagnostics . Dr. Bateman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for C2N Diagnostics . Dr. Bateman has received stock or an ownership interest from C2N Diagnostics. The institution of Dr. Bateman has received research support from Alzheimer's SILQ Research Fund/ Barnes Jewish Hospital Foundation . The institution of Dr. Bateman has received research support from National Institutes of Health- R21AG067559. The institution of Dr. Bateman has received research support from Centene Corporation. The institution of Dr. Bateman has received research support from Rainwater Charitable Foundation . The institution of Dr. Bateman has received research support from Cure Alzheimer's Fund. The institution of Dr. Bateman has received research support from Cure Alzheimer's Fund. The institution of Dr. Bateman has received research support from Anonymous Foundation. The institution of Dr. Bateman has received research support from Cure Alzheimer's Fund. The institution of Dr. Bateman has received research support from BrightFocus Foundation. The institution of Dr. Bateman has received research support from Assn for Frontotemporal Degeneration FTD Biomarkers Initiative. The institution of Dr. Bateman has received research support from Rainwater Foundation. The institution of Dr. Bateman has received research support from NIH- R01NS095773. The institution of Dr. Bateman has received research support from AbbVie/Biogen/Eli Lilly. The institution of Dr. Bateman has received research support from NIH/NINDS/NIA- RF1AG061900 (R56AG061900 & R01NS065667). The institution of Dr. Bateman has received research support from Eisai. The institution of Dr. Bateman has received research support from Good Ventures Foundation. The institution of Dr. Bateman has received research support from National Institutes of Health- R01 AG070941. The institution of Dr. Bateman has received research support from National Institutes of Health-. The institution of Dr. Bateman has received research support from National Institutes of Health. The institution of Dr. Bateman has received research support from NIH- P50AG005681-36. The institution of Dr. Bateman has received research support from NIH/NIA- U19AG032438. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Pharma Consortium. The institution of Dr. Bateman has received research support from Eli Lilly . The institution of Dr. Bateman has received research support from NIH/NIA- NIH R01AG053267. The institution of Dr. Bateman has received research support from Administrative Supplement 01- NIH . The institution of Dr. Bateman has received research support from Administrative Supplement 02- NIH . The institution of Dr. Bateman has received research support from NIH- 1U01AG059798. The institution of Dr. Bateman has received research support from NIH- R01AG068319. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Roche. The institution of Dr. Bateman has received research support from NIH/NIA- R01AG046179. The institution of Dr. Bateman has received research support from GHR; Anonymous Foundation. The institution of Dr. Bateman has received research support from NIH/NIA- 1U01AG042791, 1U01AG042791. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from NIH/State Government- 5U19AG010483. Dr. Bateman has received intellectual property interests from a discovery or technology relating to health care.
David B. Clifford, MD, FAAN	Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Excision BioTherapeutics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CellEvolve. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeuitics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity (Medpace). Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Clifford has received publishing royalties from a publication relating to health care.
Abdullah M. Al-Qudah, MD	Dr. Al-Qudah has nothing to disclose.
Mohamed Fahmy Doheim	Mr. Doheim has nothing to disclose.
Marcelo Rocha, MD, PhD	The institution of Dr. Rocha has received research support from NIH.
Lucas Rios Rocha, MD	Dr. Rios Rocha has nothing to disclose.
Anmol Almast	Miss Almast has nothing to disclose.
Jussie Correia Lima, MD	Dr. Correia Lima has nothing to disclose.
Nirav Bhatt, MD	Dr. Bhatt has nothing to disclose.
Bradley Gross, MD	Dr. Gross has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Gross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Microvention. Dr. Gross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA.
Michael Lang, MD	Dr. Lang has nothing to disclose.
Raul G. Nogueira, MD	Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus.
Matthew T. Starr, MD	Dr. Starr has nothing to disclose.
Alhamza Al-Bayati, MD	Dr. Al-Bayati has nothing to disclose.
Mary Craven	Ms. Craven has nothing to disclose.
Taylor McVeigh	Taylor McVeigh has nothing to disclose.
Devanshi Choksi, MD, MPH	Dr. Choksi has nothing to disclose.
Akashleena Mallick, MD, MBBS	Dr. Mallick has nothing to disclose.
Tanzeela Ranman	Ms. Ranman has nothing to disclose.
Christina Kourkoulis	No disclosure on file
Samantha Mora	Samantha Mora has nothing to disclose.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Nirupama Yechoor, MD	Dr. Yechoor has nothing to disclose.
Randa G. Jarrar, MD	Dr. Jarrar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralis.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Danielle A. Becker, MD	Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk life Science. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sk Life Science. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UBC. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals.
Adrian L. Rabinowicz, MD, FAAN	Dr. Rabinowicz has received personal compensation for serving as an employee of Neurelis, Inc. Dr. Rabinowicz has stock in Neurelis, Inc.
Enrique Carrazana	Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
heather romero, PhD	Dr. romero has received personal compensation for serving as an employee of Takeda. Dr. romero has stock in Takeda.
Yulia Savva, PhD	Dr. Savva has stock in Takeda. Dr. Savva has stock in Thermo Fischer.
Helen A. Doll, PhD	Dr. Doll has nothing to disclose.
Amy Howerter, PhD	Dr. Howerter has received personal compensation for serving as an employee of Clinical Outcomes Solutions.
Shruti Dave, PhD	Dr. Dave has nothing to disclose.
Stephen Crawford, PhD	Dr. Crawford has received personal compensation for serving as an employee of Takeda. Dr. Crawford has stock in Takeda.
John Diaz-Decaro, PhD, MS	Dr. Diaz-Decaro has received personal compensation for serving as an employee of Moderna. Dr. Diaz-Decaro has stock in Moderna Tx, Inc.
Philip Buck, PhD	Dr. Buck has received personal compensation for serving as an employee of Moderna, Inc. Dr. Buck has stock in Moderna, Inc.
Sigrid DaVeiga, MD	Dr. DaVeiga has received personal compensation for serving as an employee of Moderna Therapeutics. Dr. DaVeiga has stock in Moderna Therapeutics.
Enejda Senko, MS	Ms. Senko has received personal compensation for serving as an employee of Moderna. Ms. Senko has stock in Moderna.
Jennifer L. St Sauver, PhD	The institution of Dr. St Sauver has received research support from NIH, Moderna, and Exact Sciences. The institution of an immediate family member of Dr. St Sauver has received research support from Sanofi.
Susan A. Hall, PhD	Dr. Hall has received personal compensation for serving as an employee of Moderna. Dr. Hall has stock in Moderna.
Robert M. Jacobson, MD	Prof. Jacobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co.. Prof. Jacobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optum. Prof. Jacobson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Academic Pediatric Association. Prof. Jacobson has stock in 3M Company. Prof. Jacobson has stock in Abbott Laboratories. Prof. Jacobson has stock in AbbVie Company. Prof. Jacobson has stock in Adobe Inc.. Prof. Jacobson has stock in Baxter. Prof. Jacobson has stock in Becton Dickinson & Co. Prof. Jacobson has stock in Eli Lilly & Company. Prof. Jacobson has stock in Embecta. Prof. Jacobson has stock in Hubbell, Inc.. Prof. Jacobson has stock in Johnson & Johnson. Prof. Jacobson has stock in MEDTRONIC PLC F. Prof. Jacobson has stock in RPM INTERNATIONAL. Prof. Jacobson has stock in Schwab Government Money Inv. Prof. Jacobson has stock in Schwab S&P 500 Index. Prof. Jacobson has stock in Solventum Corp. Prof. Jacobson has stock in Takeda Pharma Co.. Prof. Jacobson has stock in ZIMMER BIOMET HLDGS. Prof. Jacobson has stock in Zimvie Inc.. The institution of Prof. Jacobson has received research support from National Institutes of Health. The institution of Prof. Jacobson has received research support from Moderna.
CHUN FAN, MS	Mrs. FAN has nothing to disclose.
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Ali Duarte, MD	Dr. Duarte has nothing to disclose.
Jeffrey Yang, MD	Dr. Yang has nothing to disclose.
Cynthia Crowson	Cynthia Crowson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Rheumatology.
Muhammad Athar	Muhammad Athar has nothing to disclose.
Matthew Hart, MD	Dr. Hart has nothing to disclose.
Katherine Silis	Ms. Silis has nothing to disclose.
Chitra Sivasankar, MD	Dr. Sivasankar has nothing to disclose.
Busra Delikkaya, MD	Dr. Delikkaya has nothing to disclose.
Tatchaporn Ongphichetmetha	Miss Ongphichetmetha has nothing to disclose.
Mengke Du	Mengke Du has nothing to disclose.
Nisa Vorasoot, MD	Dr. Vorasoot has nothing to disclose.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Amy Kunchok, MBBS	Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal .
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Logan McPherson	Mr. McPherson has nothing to disclose.
Sarah C. Parauda, MD	Dr. Parauda has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Panter, Panter & Sampedro.
Serena Wong, MD	Dr. Wong has nothing to disclose.
Yarden Bornovski, MD	Dr. Bornovski has nothing to disclose.
Brittany Russo, MD	Dr. Russo has nothing to disclose.
Ahya S. Ali, MD	Dr. Ali has nothing to disclose.
Andrew Bauerschmidt, MD	Dr. Bauerschmidt has nothing to disclose.
Tracey A. Milligan, MD, FAAN	Dr. Milligan has received publishing royalties from a publication relating to health care.
Areeba Nisar	Areeba Nisar has nothing to disclose.
Shreya Ghosh	Ms. Ghosh has nothing to disclose.
Victor Wang, MD, FAAN	Dr. Wang has nothing to disclose.
Suraj Malhan, DO	Dr. Malhan has nothing to disclose.
Claire Ceriani, MD	Dr. Ceriani has nothing to disclose.
Nicole M. Spare, DO	Dr. Spare has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie.
Michael J. Marmura, MD, FAAN	Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. The institution of Dr. Marmura has received research support from Axsome. The institution of Dr. Marmura has received research support from Pfizer. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Hsiangkuo Yuan, MD, PhD	An immediate family member of Dr. Yuan has received personal compensation for serving as an employee of Merck. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Salvia. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovous. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Regional Anesthesia and Pain Medicine. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Headache and Pain Reports. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. The institution of Dr. Yuan has received research support from NIH. The institution of Dr. Yuan has received research support from American Headache Society. The institution of Dr. Yuan has received research support from Pfizer. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Invited speaker with Chinese Stroke Association.
John Furey	Mr. Furey has nothing to disclose.
Alexander Sherman	The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Terry D. Heiman-Patterson, MD	Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Larisa Ibric, Medical student	Ms. Ibric has nothing to disclose.
Antonio Mutarelli	ANTONIO MUTARELLI has nothing to disclose.
Felipe B. Brunheroto	Mr. Brunheroto has nothing to disclose.
Gabriel d. Monteiro	Mr. Monteiro has nothing to disclose.
Gabriel Marinheiro, Medical student	Mr. Marinheiro has nothing to disclose.
Julyana M. Dantas, MD	Dr. Dantas has nothing to disclose.
Joao Paulo Telles	Joao Paulo Telles has nothing to disclose.
Qian Wang, MD	Dr. wang has nothing to disclose.
Yujuan Jiao	No disclosure on file
Wanprapit Noree, MD	Dr. Noree has nothing to disclose.
Ekamol Tantisattamo, MD, MPH	Dr. Tantisattamo has nothing to disclose.
Rabhas Boonyawairote, MD	Dr. Boonyawairote has nothing to disclose.
Voramol Rochanaroon	No disclosure on file
Chutawat Kookanok, MD	Dr. Kookanok has nothing to disclose.
Kanita Mankan, MD	Miss Mankan has nothing to disclose.
Nopavit Mohpichai	Mr. Mohpichai has nothing to disclose.
Seonghyeon Kim, BA	Mr. Kim has nothing to disclose.
Andrea Yanez	Ms. Yanez has nothing to disclose.
Bahaar Ghaffarian	Miss Ghaffarian has nothing to disclose.
Aryan Malhotra	Mr. Malhotra has nothing to disclose.
Isaac Thorman, ScM	Mr. Thorman has nothing to disclose.
Adam C. Kiss	Mr. Kiss has nothing to disclose.
Ariel Sacknovitz, Medical Student	Mr. Sacknovitz has nothing to disclose.
Eris Spirollari, BA	Mr. Spirollari has nothing to disclose.
Ankita Jain, MS	Miss Jain has nothing to disclose.
Fawaz Al-Mufti, MD	Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Sneh Preet Munder, MD	Dr. Munder has nothing to disclose.
Franklin McNeil IV, MD	Dr. McNeil has nothing to disclose.
Lisa Carolan, RN	Ms. Carolan has nothing to disclose.
Edward Yu, MD, FAAN	Dr. Yu has nothing to disclose.
Tala Mohammad	Ms. Mohammad has nothing to disclose.
Mira A. Bishtawi, Sr., MD	Miss Bishtawi has nothing to disclose.
Randa M. Shahwan, MD	Ms. Shahwan has nothing to disclose.
Jaber H. Jaradat, MD	Dr. Jaradat has nothing to disclose.
Omar F. Jbarah, MD	Dr. Jbarah has nothing to disclose.
Ethar Hazaimeh, MD	Dr. Hazaimeh has nothing to disclose.
Mohammad M. Hamad	Mr. Hamad has nothing to disclose.
Ruoyi Zheng	Ruoyi Zheng has nothing to disclose.
Yuqiao Liao	No disclosure on file
Muzi Wen	Muzi Wen has nothing to disclose.
Wenbin Pan	Mr. Pan has nothing to disclose.
Gaoling Li, MBBS	Mr. Li has nothing to disclose.
Pei Shang, MD, PhD	Dr. Shang has nothing to disclose.
Cleopatra Elshiekh	Miss Elshiekh has nothing to disclose.
Ashley Phillips	No disclosure on file
Ashley M. Marie Rodriguez	Miss Marie Rodriguez has nothing to disclose.
Bharat Narang	No disclosure on file
Francesca Gany	Francesca Gany has nothing to disclose.
Joshua A. Budhu, MD	Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Budhu has received research support from BMSF. The institution of Dr. Budhu has received research support from Commonwealth Fund. The institution of Dr. Budhu has received research support from National Cancer Institute . The institution of Dr. Budhu has received research support from Memorial Sloan Kettering Cancer Center. The institution of Dr. Budhu has received research support from United Hospital Fund. Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as a Peer Reviewer with Medscape.
Samden Lhatoo, MD	Dr. Lhatoo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova. The institution of Dr. Lhatoo has received research support from NIH. Dr. Lhatoo has received intellectual property interests from a discovery or technology relating to health care. Dr. Lhatoo has received publishing royalties from a publication relating to health care.
Wesley Kerr, MD, PhD	Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from ��ɫ��. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care.
Elaine C. Wirrell, MD, FAAN	Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Elizabeth Donner, MD, FRCPC	Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seizure. The institution of Dr. Donner has received research support from SickKids Centre for Brain and Mental Health. The institution of Dr. Donner has received research support from Ontario Brain Institute. The institution of Dr. Donner has received research support from CIHR.
Joseph E. Sullivan, MD	Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrightMinds. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Sullivan has stock in Zynerba. The institution of Dr. Sullivan has received research support from Stoke. The institution of Dr. Sullivan has received research support from Takeda. The institution of Dr. Sullivan has received research support from Neurocrine. The institution of Dr. Sullivan has received research support from Encoded. The institution of Dr. Sullivan has received research support from Zogenix.
Renzo Guerrini	Renzo Guerrini has nothing to disclose.
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO	Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Chiesi . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Biohaven Ltd. that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Bright Minds Biosciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neuren Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Praxis Precision Medicines that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Shanghai Zhimeng Biopharma that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Supernus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with UCB Biopharma SRL that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ultragenyx that is relevant to AAN interests or activities.
Sylvain Rheims	No disclosure on file
J. Helen Cross	Dr. Cross has nothing to disclose.
Lieven G. Lagae, PhD	Dr. Lagae has nothing to disclose.
Philippe Ryvlin, MD, PhD	Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle/Angelini. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma. The institution of Dr. Ryvlin has received research support from Swiss National Fund. The institution of Dr. Ryvlin has received research support from European Commission (Horizon Europe).
Antonio Gil-Nagel, MD	Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Jeffrey Noebels, MD, PhD	No disclosure on file
Jenna S. Roberts, PhD	Dr. Roberts has received personal compensation for serving as an employee of UCB Pharma. Dr. Roberts has stock in UCB Pharma.
Amelie Lothe, PhD	Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has stock in UCB.
Milena Tryfon, MSc	Mrs. Tryfon has received personal compensation for serving as an employee of UCB Pharma.
Michael Ranopa, PhD	Dr. Ranopa has stock in UCB.
Orrin Devinsky, MD, FAAN	Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Laura Finn, MD	Miss Finn has nothing to disclose.
Lucas B. Kotecki	Mr. Kotecki has nothing to disclose.
Fatima V. Leite, Medical student (MS)	Miss Leite has nothing to disclose.
Felipe A. Gouhie	Mr. Gouhie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marjan Farma.
Pedro Grossi	Mr. Grossi has nothing to disclose.
Anna V. de Vasconcelos	Miss de Vasconcelos has nothing to disclose.
Rebecca Stafford	Ms. Stafford has nothing to disclose.
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Ali Daneshmand, MD	Dr. Daneshmand has nothing to disclose.
Brian J. Coffey, MD	Dr. Coffey has nothing to disclose.
Ika Noviawaty, MD	Dr. Noviawaty has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceutical/CME Outfitter. The institution of Dr. Noviawaty has received research support from MARINUS. The institution of Dr. Noviawaty has received research support from UCB.
Alexander T. Scott, Research coordinator	Mr. Scott has nothing to disclose.
Isabelle Xu, BA	Miss Xu has nothing to disclose.
Muhannad Seyam, MD	Dr. Seyam has nothing to disclose.
Rachel Thompson	Miss Thompson has nothing to disclose.
Jiayi Luo	Ms. Luo has nothing to disclose.
Syed M. Jafri	Mr. Jafri has nothing to disclose.
Joan Skelly	Joan Skelly has nothing to disclose.
Waqar Waheed, MD, MBBS	Dr. Waheed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Rup Tandan, MD, FRCP, FAAN	Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics.
Rebeca O. Silva, Student	Miss Silva has nothing to disclose.
Frederico M. de Sousa Marinho Mendes Filho	Mr. de Sousa Marinho Mendes Filho has nothing to disclose.
Giovanna Salema Pascual	Miss Salema Pascual has nothing to disclose.
Saul Dominici, Sr.	Dr. Dominici has nothing to disclose.
Elizabet Taylor P. Weba, Jr., Student	Miss Weba has nothing to disclose.
David B. Abraham, MS	Mr. Abraham has nothing to disclose.
Christian K. Fukunaga, MS (Medical Student)	Mr. Fukunaga has nothing to disclose.
Rafaela Farias Vidigal Nascimento, MD	Miss Nascimento has nothing to disclose.
Daniel V. De Siqueira Lima, Jr., MD	Dr. De Siqueira Lima has nothing to disclose.
João Pedrosa	Mr. Pedrosa has nothing to disclose.
Yves Dauvilliers, MD, PhD	Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Bioscience.
Emmanuel Mignot, MD, PhD	Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa .
Giuseppe Plazzi, MD	The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TAKEDA. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOPROJET. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA/CENTESSA.
Gerrit J. Lammers, MD	The institution of Dr. Lammers has received research support from Takeda.
Harisha Kadali, MBBS	Dr. Kadali has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Kadali has stock in Takeda Pharmaceuticals.
Ellie Stukalin, PhD	Dr. Stukalin has received personal compensation for serving as an employee of Takeda. Dr. Stukalin has stock in Takeda.
Yaming Hang, PhD	Dr. Hang has received personal compensation for serving as an employee of Takeda.
Yeting Du	Yeting Du has received personal compensation for serving as an employee of Takeda Pharmaceuticals.
Anson Abraham, PhD	Dr. Abraham has received personal compensation for serving as an employee of Takeda Pharmaceutical Company. Dr. Abraham has stock in Takeda.
Sebastian F. Von Rosenstiel, MD, PhD	Dr. Von Rosenstiel has received personal compensation for serving as an employee of Takeda. Dr. Von Rosenstiel has stock in Takeda.
Shinichiro Tanaka, PhD	Mr. Tanaka has received personal compensation for serving as an employee of Takeda.
Melissa Naylor	Ms. Naylor has received personal compensation for serving as an employee of Takeda. Ms. Naylor has stock in Takeda.
Alice Cai, MD	Dr. Cai has received personal compensation for serving as an employee of Takeda.
Tina Olsson, PhD	Dr. Olsson has received personal compensation for serving as an employee of Takeda. Dr. Olsson has stock in Takeda.
Elizabeth A. Johnson, PhD	Dr. Johnson has received personal compensation for serving as an employee of Acumen Pharmaceuticals.
Erika N. Cline, PhD	Dr. Cline has received personal compensation for serving as an employee of Acumen Pharmaceuticals. Dr. Cline has stock in Acumen Pharmaceuticals.
Karen Sundell	Karen Sundell has received personal compensation for serving as an employee of Acumen Pharmaceuticals . Karen Sundell has stock in Acumen Pharmaceuticals .
Daniel Antwi-Berko, PhD	Dr. Antwi-Berko has nothing to disclose.
Marleen J. Koel-Simmelink, Dr	Dr. Koel-Simmelink has nothing to disclose.
Charlotte Teunissen, PhD	Prof. Teunissen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Prof. Teunissen has received publishing royalties from a publication relating to health care.
Eric R. Siemers, MD	Dr. Siemers has received personal compensation for serving as an employee of Acumen Pharmaceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Vaccinex Pharmceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Gates Ventures LLC. Dr. Siemers has or had stock in Acumen Pharmaceuticals.Dr. Siemers has or had stock in Ell Lilly and Company.Dr. Siemers has received personal compensation in the range of $0-$499 for serving as a study section reviewer with National Institutes of Health. Dr. Siemers has a non-compensated relationship as a Volunteer with Alzheimer's Association that is relevant to AAN interests or activities.
Hao Zhang, PhD	Dr. Zhang has received personal compensation for serving as an employee of Acumen Pharmaceuticals.
Maddelyn Hyland, MPH	Miss Hyland has received personal compensation for serving as an employee of Acumen Pharmaceuticals.
Gopalan Sethuraman	Dr. Sethuraman has received personal compensation for serving as an employee of Acumen Pharmaceuticals. Dr. Sethuraman has stock in Acumen Pharmaceuticals.
Hugo M. Vanderstichele, PhD	Dr. Vanderstichele has received personal compensation in the range of $0-$499 for serving as a Consultant for Acumenpharm.
june kaplow, PhD	Dr. kaplow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Acumen Pharmaceuticals Inc.
Robert A. Dean	Robert A. Dean has received personal compensation for serving as an employee of Acumen Pharmaceutics. Robert A. Dean has received personal compensation for serving as an employee of Gates Ventures. Robert A. Dean has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Robert A Dean Consulting, LLC. Robert A. Dean has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Jasna Jerecic, PhD	Dr. Jerecic has received personal compensation for serving as an employee of Acumen Pharmaceuticals Inc.
Sydni Paleczny, MSc	Ms. Paleczny has nothing to disclose.
Kimia Honarmand, MD, PhD	The institution of Dr. Honarmand has received research support from CIHR (indirect through ACT consortium).
Dave Nagpal, MD	Dr. Nagpal has nothing to disclose.
Emilie P. Belley-cote, MD	The institution of Dr. Belley-cote has received research support from Bayer. The institution of Dr. Belley-cote has received research support from Abbott. The institution of Dr. Belley-cote has received research support from Roche Diagnostics. Dr. Belley-cote has received personal compensation in the range of $500-$4,999 for serving as a consultant with Trimedic Therapeutics.
Richard Whitlock, MD, PhD	Prof. Whitlock has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atricure. The institution of Prof. Whitlock has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston scientific . Prof. Whitlock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Procyrion. The institution of Prof. Whitlock has received research support from Atricure. The institution of Prof. Whitlock has received research support from Boston scientific.
Adrian Owen	Adrian Owen has stock in Creyos Inc.
Gerome B. Vallejos, MD	Mr. Vallejos has nothing to disclose.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Gabriela Romanow	Gabriela Romanow has nothing to disclose.
Gilbert Lefèvre, PhD	Dr. Lefèvre has nothing to disclose.
Xianbin Tian, PhD	Dr. Tian has received personal compensation for serving as an employee of Novartis. Dr. Tian has stock in Novartis. Dr. Tian has a non-compensated relationship as a Director of PKS with Novartis that is relevant to AAN interests or activities.
somesh choudhury, PhD	Dr. choudhury has nothing to disclose.
Roman Willi, PhD	Dr. Willi has received personal compensation for serving as an employee of Novartis Pharma. Dr. Willi has received stock or an ownership interest from Novartis.
Bernd C. Kieseier, MD	Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Yang Liu	Mrs. Liu has nothing to disclose.
Robert BEECHAM, MSc BSc RGN	Mr. BEECHAM has nothing to disclose.
Stefan V. Vormfelde, MD	Dr. Vormfelde has received personal compensation for serving as an employee of Novartis. Dr. Vormfelde has stock in Novartis.
Hanns-Christian Tillmann, MD	Dr. Tillmann has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Tillmann has stock in Novartis Pharma AG. Dr. Tillmann has stock in Alcon . Dr. Tillmann has stock in Sandoz.
Mar Guasp, MD	Dr. Guasp has nothing to disclose.
Juan Fran Luchoro Cerda	Mr. Luchoro Cerda has nothing to disclose.
Raquel Ruiz García, PhD	Dr. Ruiz García has nothing to disclose.
Carmen Martínez, MD, PhD	Prof. Martínez has nothing to disclose.
Francesc R. Graus, MD	Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care.
Montserrat Rovira, MD	Dr. Rovira has nothing to disclose.
Francesc F. Avilés, MD, PhD	Dr. Avilés has nothing to disclose.
María Suarez-Lledo, PhD	Mrs. Suarez-Lledo has nothing to disclose.
Albert Saiz	Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Ankush Maheshwary, MBBS	Dr. Maheshwary has nothing to disclose.
Erica A. Schuyler, MD, FAAN	Dr. Schuyler has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Stanfield Bechtel Law, LLC.
Nida Akram, MBBS	No disclosure on file
Syed D. Asad, MD	Dr. Asad has nothing to disclose.
Unaiza Memon	Dr. Memon has nothing to disclose.
Faisal R. Jahangiri, MD, DABNM, FASNM, FASET	Prof. Jahangiri has nothing to disclose.
Ariyaporn Haripottawekul	Miss Haripottawekul has nothing to disclose.
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Ali Mahta, MD	Dr. Mahta has received research support from Brown University Health.
Timothy Beutler, MD	Dr. Beutler has nothing to disclose.
Darshana Vijaywargiya, MBBS	Dr. Vijaywargiya has nothing to disclose.
Raahim Bashir, MD	Dr. Bashir has nothing to disclose.
Rajiv Mangla, MD	Dr. Mangla has nothing to disclose.
Paul Mehta	No disclosure on file
Jaime Raymond	Jaime Raymond has nothing to disclose.
Theresa Nair, MPH	Ms. Nair has nothing to disclose.
Moon Han, PhD	Dr. Han has nothing to disclose.
Jasmine Berry	Jasmine Berry has nothing to disclose.
Theodore Larson	Theodore Larson has nothing to disclose.
Suraya Mohidul, MPH	Miss Mohidul has nothing to disclose.
D Kevin Horton	No disclosure on file
Mahrin Rahman, DO	Dr. Rahman has nothing to disclose.
Andrew Osborne, MD	Dr. Osborne has nothing to disclose.
Suman Bharath, MD	Dr. Bharath has nothing to disclose.
Maranatha Ayodele, MD	Dr. Ayodele has nothing to disclose.
Tristine Onuski, NP	Ms. Onuski has nothing to disclose.
Abyaz Asmar, MD	Dr. Asmar has nothing to disclose.
Summaiyya Waseem	Summaiyya Waseem has nothing to disclose.
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Louis Ferrari	No disclosure on file
Amaal J. Starling, MD, FAAN	Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
David B. Kudrow, MD	Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Neha Kapur	Neha Kapur has received personal compensation for serving as an employee of Lundbeck. An immediate family member of Neha Kapur has stock in Doordash.
Foram V. Patel, PharmD	Dr. Patel has nothing to disclose.
Jessica Ailani, MD, FAAN	Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Sari W. Grossman	Ms. Grossman has received personal compensation for serving as an employee of Lundbeck. Ms. Grossman has received personal compensation for serving as an employee of Horizon Therapeutics.
Susanne Awad	Susanne Awad has received personal compensation for serving as an employee of Lundbeck.
Vishal Mehta, MD	Dr. Mehta has nothing to disclose.
Divya Jyoti, MD	Dr. Jyoti has nothing to disclose.
Ujjawal Sahay, MBBS	Dr. Sahay has nothing to disclose.
Rishi T. Guria III, MD	Dr. Guria has nothing to disclose.
Emily R. Fisher, MD	Dr. Fisher has nothing to disclose.
Amna Sohail, MD	Dr. Sohail has nothing to disclose.
Saagar Sheth	Mr. Sheth has nothing to disclose.
Chad M. Aldridge, PT	Dr. Aldridge has nothing to disclose.
Vitoria Pinheiro, BSc	Miss Pinheiro has nothing to disclose.
Isabelle R. Menezes	Miss Menezes has nothing to disclose.
Igor M. Rocha, Medical Student	Mr. Rocha has nothing to disclose.
Kenzo Ogasawara, MD	Dr. Ogasawara has nothing to disclose.
Ruoyu Li	Miss Li has nothing to disclose.
Peidong Liu	The institution of Dr. Liu has received research support from China.
Hongbo Liu	The institution of Hongbo Liu has received research support from China.
Xinlin Wang	Dr. Wang has nothing to disclose.
Michael Chez, MD, FAAN	Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelsi. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst.
Pavel Klein, MD, FAAN	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Jurriaan Peters, MD	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UCB.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Pranav Gandhi	Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Rashmi B. Halker Singh, MD, FAAN	Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
Jonathan Stokes	Jonathan Stokes has nothing to disclose.
Kandavadivu Umashankar	Kandavadivu Umashankar has received personal compensation for serving as an employee of AbbVie.
Brett Dabruzzo, PharmD	Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Molly Duan	Molly Duan has received personal compensation for serving as an employee of AbbVie.
Andreas Gantenbein, MD	Prof. Gantenbein has nothing to disclose.
Paul Mehta	Paul Mehta has nothing to disclose.
Reshma Punjani	Reshma Punjani has nothing to disclose.
Elizabeth Zeldin, Medical Student	Ms. Zeldin has nothing to disclose.
R.Alejandro (Alex) A. Sica, MD	The institution of Dr. Sica has received research support from Kite.
Kith Pradhan, PhD	Dr. Pradhan has nothing to disclose.
NIshi Shah, MD	Dr. Shah has nothing to disclose.
Dennis L. Cooper, MD	Dr. Cooper has nothing to disclose.
Lauren C. Shapiro, MD	Dr. Shapiro has nothing to disclose.
Kira Gritsman, MD, PhD	The institution of Dr. Gritsman has received research support from NIH/NIDDK.
Katharine A. McNicol, MD	An immediate family member of Dr. McNicol has received personal compensation for serving as an employee of Siemens Healthineers.
Mark Milstein, MD, FAAN	Dr. Milstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Milstein has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Milstein has received publishing royalties from a publication relating to health care. Dr. Milstein has a non-compensated relationship as a Board of Directors with New York County Medical Society that is relevant to AAN interests or activities.
Samantha J. Cheng, MD	Dr. Cheng has nothing to disclose.
Lei Liu, MD, PhD	Dr. Liu has nothing to disclose.
Jingxiao Zhang	Dr. Zhang has nothing to disclose.
Alexa Keeling, MD, MSc	Dr. Keeling has nothing to disclose.
Vijay Daniels, MD	Dr. Daniels has nothing to disclose.
Rula A. AlShimi	Ms. AlShimi has nothing to disclose.
Abdel Qader Abu-Salih, MD	Mr. Abu-Salih has nothing to disclose.
Mohammad Al-Bdour	Mohammad Al-Bdour has nothing to disclose.
Ahmad A. Alkabi, MD	Mr. Alkabi has nothing to disclose.
Leonardo Pipek, MD	Dr. Pipek has nothing to disclose.
Letícia F. Saldanha, MS	Miss Saldanha has nothing to disclose.
Pedro Henrique Reginato	Mr. Reginato has nothing to disclose.
Gabriel P. Mantovani	Mr. Mantovani has nothing to disclose.
Vinicius Castro	Mr. Castro has nothing to disclose.
Michael Chojnacki	Mr. Chojnacki has nothing to disclose.
Michael Chen, MD	Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RapidPulse. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Balt. Dr. Chen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Chen has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Neurointerventional Surgery. Dr. Chen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurointerventional Surgery. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johnson.
Andrew Cutler	Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for AbbVie. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Alkermes. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Axsome. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Boehringer Ingelheim. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Myers Squibb. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Delpor. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for 4M Therapeutics. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for J&J. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Jazz Pharma. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for MapLight Therapeutics. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Neumora. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurocrine. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Noven. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Otsuka. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Relmada. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Supernus. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Andrew Cutler has received personal compensation in the range of $0-$499 for serving as a Consultant for Tris Pharma. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for COMPASS Pathways. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Freedom Biosciences. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AbbVie. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkermes. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Axsome. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for J&J. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lundbeck. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Neurocrine. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Noven. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Otsuka. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Supernus. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Tris Pharma. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Vanda Pharmaceuticals. Andrew Cutler has stock in 4M Therapeutics. Andrew Cutler has stock in Relmada.
Craig Chepke	Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Craig Chepke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Craig Chepke has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acadia. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Otsuka. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Takeda. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Janssen. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ironshore. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Intracellular. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Craig Chepke has received research support from Acadia. Craig Chepke has received research support from Harmony. Craig Chepke has received research support from Neurocrine.
Nathaniel F. Watson, MD	Dr. Watson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Watson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for React Health. Dr. Watson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony Biosciences.
Shawn A. Candler, MD	Dr. Candler has received research support from Jazz Pharmaceuticals .
Douglas S. Fuller	Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals.
Thomas Measey	Thomas Measey has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Thomas Measey has stock in Jazz Pharmaceuticals.
Brian Scheckner	Brian Scheckner has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Brian Scheckner has stock in Jazz Pharmaceuticals.
Sarah Akerman, MD	Dr. Akerman has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Akerman has stock in Jazz Pharmaceuticals.
Idha Sood	Dr. Sood has nothing to disclose.
Archana Kaushik, MBBS	Ms. Kaushik has nothing to disclose.
Aishwarya J, MD	Ms. J has nothing to disclose.
Fathimathul Henna, MBBS, Student	Miss Henna has nothing to disclose.
Ashvath A. Pillai, Student	Mr. Pillai has nothing to disclose.
Carlos A. Rodríguez Alarcón, MD	Dr. Rodríguez Alarcón has nothing to disclose.
Danny J. Japon	Mr. Japon has nothing to disclose.
Ricardo Murguia Fuentes, MD	Dr. Murguia Fuentes has nothing to disclose.
Presley M. Gruezo, Jr.	Mr. Gruezo has nothing to disclose.
Linker E. Viñan Paucar, Sr.	Mr. Viñan Paucar has nothing to disclose.
Daniella A. Bustamante, MD	Dr. Bustamante has nothing to disclose.
Rocio A. Santibanez, MD, FAAN	Dr. Santibanez has nothing to disclose.
Luis Yepez	Luis Yepez has nothing to disclose.
Shelby Freeman, MD	Dr. Freeman has nothing to disclose.
Kunal Bhatia, MD	Dr. Bhatia has nothing to disclose.
Luis A. Shimose, MD	Dr. Shimose has nothing to disclose.
Kevin K. Horton, PhD	Dr. Horton has nothing to disclose.
Michelle Troup, MD	The institution of Ms. Troup has received research support from International association of medical science educators .
Jillian M. Berkman, MD	Dr. Berkman has received personal compensation in the range of $0-$499 for serving as a Consultant for Medzown. Dr. Berkman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Veterans Affairs. Dr. Berkman has stock in Medzown.
Christopher M. Duma II, MD	Dr. Duma has received personal compensation for serving as an employee of Regeneration Biomedical, Inc.. Dr. Duma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longeviti Inc.. Dr. Duma has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Regeneration Biomedical, Inc.. Dr. Duma has stock in Regeneration Biomedical, Inc.. Dr. Duma has received intellectual property interests from a discovery or technology relating to health care.
Hans Keirstead, PhD	Dr. Keirstead has received personal compensation for serving as an employee of AIVITA Biomedical. Dr. Keirstead has received personal compensation for serving as an employee of Human Immunome Project. Dr. Keirstead has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Immunis . Dr. Keirstead has stock in AIVITA Biomedical. Dr. Keirstead has stock in Immunis. Dr. Keirstead has received intellectual property interests from a discovery or technology relating to health care.
Gabriel Nistor, MD	Dr. Nistor has received personal compensation for serving as an employee of Aivita Biomedical. Dr. Nistor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life and Land Prospect.
Jessica Buxton, BA	Miss Buxton has nothing to disclose.
Sawyer H. Farmer	Mr. Farmer has nothing to disclose.
Robert Lynn, Sr., BS	Mr. Lynn has received personal compensation for serving as an employee of Regeneration Biomedical, Inc..
Karlyssa Chung, PA	Prof. Chung has nothing to disclose.
Zoe Hareng, PA	Ms. Hareng has nothing to disclose.
Gerardo M. Luna-Peralta	Mr. Luna-Peralta has nothing to disclose.
Karlos A. Acurio, MD	Mr. Acurio has nothing to disclose.
Ivan Alegre-Cordero	Mr. Alegre-Cordero has nothing to disclose.
Jeancarlo Velazco	Mr. Velazco has nothing to disclose.
Fritz F. Vascones Roman, Sr.	Mr. Vascones Roman has nothing to disclose.
Guillermo Mantilla	Dr. Mantilla has nothing to disclose.
Carlos Rodrigo Q. Vicuña	Mr. Vicuña has nothing to disclose.
Roman Herzig, MD, PhD	Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Roman Herzig, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Care Comm.
Igor Gunka, MD, PhD	Dr. Gunka has nothing to disclose.
Svatopluk Ostry, MD, PhD	Dr. Ostry has nothing to disclose.
Jiri Fiedler, MD, PhD	Dr. Fiedler has nothing to disclose.
Vladimir Priban, MD, PhD	Dr. Priban has nothing to disclose.
Martin Kovar, MD	The institution of Dr. Kovar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PHRI. Dr. Kovar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Kovar has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Kovar has received research support from StroCzech Research Network.
Petr Stadler, MD, PhD	Prof. Stadler has received publishing royalties from a publication relating to health care.
Ondrej Skoda, MD	Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Meditorial.
Jiri J. Neumann, MD, FESO	Mr. Neumann has received personal compensation for serving as an employee of Boehringer Ingelheim. Mr. Neumann has received personal compensation for serving as an employee of Teva. Mr. Neumann has received personal compensation for serving as an employee of Novartis. Mr. Neumann has received personal compensation for serving as an employee of Pfizer.
Veronika Kunesova, PhD	Dr. Kunesova has nothing to disclose.
Christopher Kendall K. Rains, Jr., MD	Mr. Rains has nothing to disclose.
Kelsey Hillhouse, MD	Dr. Carr has nothing to disclose.
Manasa Gunturu, MD	Dr. Gunturu has nothing to disclose.
Sukriye Damla Kara, MD	Dr. Kara has nothing to disclose.
Lindsey M. Ladd, DO	Dr. Ladd has nothing to disclose.
Gerhardt Pohl, PhD	Dr. Pohl has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Pohl has stock in Eli Lilly. Dr. Pohl has stock in Jazz Pharmaceuticals.
Leah Burn, PhD	Dr. Burn has nothing to disclose.
Shuo Cao, PhD	Dr. Cao has nothing to disclose.
Weiyi Ni	Weiyi Ni has received personal compensation for serving as an employee of Jazz Pharmaceuticals. An immediate family member of Weiyi Ni has received personal compensation for serving as an employee of LoanDepot. Weiyi Ni has stock in Jazz Pharmaceuticals. An immediate family member of Weiyi Ni has stock in LoanDepot.
Hema Viswanathan	Ms. Viswanathan has received personal compensation for serving as an employee of Allergan plc. Ms. Viswanathan has received personal compensation for serving as an employee of Precision Medicine Group. Ms. Viswanathan has received stock or an ownership interest from Allergan plc. Ms. Viswanathan has received stock or an ownership interest from Precision Medicine Group.
Timothy B. Saurer, PhD	Dr. Saurer has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Saurer has stock in Jazz Pharmaceuticals.
Rodrigo Sanjinez, Sr., MD	Dr. Sanjinez has nothing to disclose.
Santiago Bestoso, MD	No disclosure on file
Juan I. Kenny, MD	Dr. Kenny has nothing to disclose.
Messoud Ashina, MD, PhD	Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Incyte. The institution of Dr. Ashina has received research support from The Lundbeck Foundation. The institution of Dr. Ashina has received research support from Novo Nordisk Foundation . The institution of Dr. Ashina has received research support from Danish National Research Foundation . Dr. Ashina has received publishing royalties from a publication relating to health care.
Seema Soni-Brahmbhatt	Seema Soni-Brahmbhatt has nothing to disclose.
Nathan Chu, MD	Dr. Chu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Jodie Roberts, MD, MSc, FRCPC	Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Novartis. Dr. Roberts has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with EMD Serono.
David J. Hunt, MD	Dr. Hunt has nothing to disclose.
Donna Kuipers, RN	Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sentrex. Ms. Kuipers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apotex.
Jomana Morkous, Research Assistant	Ms. Morkous has nothing to disclose.
Kyra West	Ms. West has nothing to disclose.
Ana-Luiza Sayao, MD	Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Robert L. Carruthers, MD	Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Virginia A. Devonshire, MD	Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck- Serono. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen . Dr. Devonshire has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for novartis. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for roche. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biogen .
Izanne Roos	Izanne Roos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Izanne Roos has received research support from MSIF-ARSEP. Izanne Roos has received research support from Melbourne Research Scholarship. Izanne Roos has received personal compensation in the range of $0-$499 for serving as a travel support with Merck. Izanne Roos has received personal compensation in the range of $0-$499 for serving as a travel support with Roche.
Tomas Kalincik	Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group chair with MSBase Foundation that is relevant to AAN interests or activities.
Alice J. Schabas, MD	Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen.
Hamza Muhammad, MBBS	Dr. Muhammad has nothing to disclose.
Syeda Umbreen Munir, MBBS	Dr. Munir has nothing to disclose.
Fizza Tariq, MD	Dr. Tariq has nothing to disclose.
Zebulnisa Khan, MBBS	Ms. Khan has nothing to disclose.
Um e Habibah	Um e Habibah has nothing to disclose.
Ramsha Rasheed, MBBS	Dr. Rasheed has nothing to disclose.
Aneeqa Mahmood, BS in Clinical Psychology	Dr. Mahmood has nothing to disclose.
Mehak Lohana, MBBS	Miss Lohana has nothing to disclose.
Kiran Batool, MBBS	Dr. Batool has nothing to disclose.
Laibah A. Kefalogianni, MD	Dr. Kefalogianni has nothing to disclose.
Eshan Kumar	Eshan Kumar has nothing to disclose.
FNU Kalpina, MBBS	Dr. Ramesh has nothing to disclose.
Rebecca Salky	Rebecca Salky has nothing to disclose.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Mattia Wruble, MD	The institution of Dr. Wruble has received research support from Alexion. The institution of Dr. Wruble has received research support from Roche.
Batuhan Ayci, MD	Mr. Ayci has nothing to disclose.
Ogeday Derin Gorkey, MD	Dr. Gorkey has nothing to disclose.
Elif Everest, PhD	Ms. Everest has received personal compensation in the range of $50,000-$99,999 for serving as a postdoctoral visiting fellow with National Institutes of Health.
Melih Tutuncu, MD	Dr. Tutuncu has nothing to disclose.
Sabahattin Saip	Sabahattin Saip has nothing to disclose.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Ugur Uygunoglu	Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Micah Sy, MD	Dr. Sy has nothing to disclose.
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Jordana Sandy, DO	Dr. Sandy has nothing to disclose.
Elizabeth H. de Farias II, medical academic	Mrs. de Farias has nothing to disclose.
Aishwarya Koppanatham, MBBS	Ms. Koppanatham has nothing to disclose.
Altair P. de Melo Neto, Student	Mr. de Melo Neto has nothing to disclose.
Julia Cappi Aguiar Moraes Souza, MS	Ms. Cappi Aguiar Moraes Souza has nothing to disclose.
Raphael Besborodco, MD	Dr. Besborodco has nothing to disclose.
Gabrielle d. Rocha, PhD	Prof. Rocha has nothing to disclose.
Mariam Tadross	Ms. Tadross has nothing to disclose.
Liza Smirnoff, MD	The institution of Dr. Smirnoff has received research support from NIH NeuroNext.
Sofia Parellada, MS	Miss Parellada has nothing to disclose.
Niels V. Pacheco, MD	Mr. Pacheco has nothing to disclose.
Wagner Rios-Garcia	Mr. Rios-Garcia has nothing to disclose.
Irving G. Calisaya-Madariaga, Sr.	Mr. Calisaya-Madariaga has nothing to disclose.
Zinnia Brenda B. Cuyotupa Cosme	Zinnia Brenda B. Cuyotupa Cosme has nothing to disclose.
Andre Lapeyre Rivera	Mr. Lapeyre Rivera has nothing to disclose.
Diana Carolina Salazar Flores, MD	Dr. Salazar Flores has nothing to disclose.
Lyan Chang, MD	Dr. Chang has nothing to disclose.
Ariana Alvarez-Rojas, Student	Miss Alvarez-Rojas has nothing to disclose.
Olivier Uwishema, MD	Dr. Uwishema has nothing to disclose.
Piero Barbanti, MD	Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fondazione Ricerca e Salute. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Barbanti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Visufarma. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Assosalute. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli-Lilly. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Barbanti has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. Dr. Barbanti has received publishing royalties from a publication relating to health care.
Cinzia Aurilia, MD	No disclosure on file
Gabriella Egeo	No disclosure on file
Bianca Orlando	No disclosure on file
Giulia F. Fiorentini, Psychologist	Dr. Fiorentini has nothing to disclose.
Sabina Cevoli	Sabina Cevoli has nothing to disclose.
Paola Torelli	No disclosure on file
Florindo d'Onofrio	No disclosure on file
Stefano Bonassi	No disclosure on file
Antonio Carnevale	No disclosure on file
Alice Mannocci, PhD	Prof. Mannocci has nothing to disclose.
Cinzia Finocchi	No disclosure on file
Simone Quintana, MD	Dr. Quintana has nothing to disclose.
Monica Laura Bandettini di Poggio	No disclosure on file
Marco Russo, MD, PhD	Dr. Russo has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Lundbeck.
Sofia Marini, MD	Dr. Marini has nothing to disclose.
Raffaele Iorio, MD	Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Therapeutics. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson.
Elia Sechi, MD	Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Silvia Falso, MD	Dr. Falso has nothing to disclose.
Martina Marini, MD	Mrs. Marini has nothing to disclose.
Pietro Zara, MD	Dr. Zara has nothing to disclose.
Pietro Businaro	Pietro Businaro has nothing to disclose.
Paolo Solla, MD	Dr. Solla has nothing to disclose.
Matteo Gastaldi, MD, PhD	Dr. Gastaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion, Roche, UCB, J&J. The institution of Dr. Gastaldi has received research support from Italian Ministry of Health, FISM, AE alliance.
Giovanni Sotgiu, MD, PhD	Prof. Sotgiu has nothing to disclose.
Salvatore A. Masala	Prof. Masala has nothing to disclose.
Matteo Paoletti, MD	Dr. PAOLETTI has nothing to disclose.
Anna Pichiecchio, MD	Prof. Pichiecchio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guerbet. Prof. Pichiecchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicu ther. Prof. Pichiecchio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer.
Mariangela Puci, PhD	Dr. Puci has nothing to disclose.
Giacomo Greco	Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Giacomo Greco has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Rossella Meloni, MD	Dr. Meloni has nothing to disclose.
Maria Luisa Usai, MD	Dr. Usai has nothing to disclose.
Sabrine Othmani, MD	Dr. Othmani has nothing to disclose.
Davide Turilli, MD	Dr. Turilli has nothing to disclose.
Atakan Selte, MD	Dr. Selte has nothing to disclose.
Leandro Sanz	Leandro Sanz has nothing to disclose.
Cecile Andris, MD	Dr. Andris has nothing to disclose.
Aurore Thibaut	No disclosure on file
Stephen Larroque	Mr. Larroque has nothing to disclose.
Claire Bernard	Mrs. Bernard has nothing to disclose.
Roland Hustinx	No disclosure on file
Steven Laureys	No disclosure on file
Arianna Sala, PhD	Dr. Sala has nothing to disclose.
Olivia Gosseries	Olivia Gosseries has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Jeffrey B. Gelblum, MD, FAAN	Dr. Gelblum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Gelblum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly . Dr. Gelblum has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai.
Katie Yoest, PhD	Dr. Yoest has received personal compensation for serving as an employee of MedThink SciCom.
David C. Weisman, MD	Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iqvia. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weisman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eisai. Dr. Weisman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lantheus. Dr. Weisman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Weisman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. The institution of Dr. Weisman has received research support from Eisai. The institution of Dr. Weisman has received research support from Biogen. The institution of Dr. Weisman has received research support from Roche. The institution of Dr. Weisman has received research support from Vivoryon. The institution of Dr. Weisman has received research support from Lilly. The institution of Dr. Weisman has received research support from Acumen. The institution of Dr. Weisman has received research support from Cerevel. The institution of Dr. Weisman has received research support from Sage. The institution of Dr. Weisman has received research support from Annovis. The institution of Dr. Weisman has received research support from Serono. The institution of Dr. Weisman has received research support from Acadia. The institution of Dr. Weisman has received research support from Alnylam. The institution of Dr. Weisman has received research support from Ventus. The institution of Dr. Weisman has received research support from Cognition. Dr. Weisman has received intellectual property interests from a discovery or technology relating to health care. Dr. Weisman has received intellectual property interests from a discovery or technology relating to health care. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Peripheral and Central Nervous System Drugs Advisory Committee with FDA.
Rafay Khan	Mr. Khan has nothing to disclose.
Mateusz Faltyn, CTO	Mr. Faltyn has nothing to disclose.
Enchao Qiu	Enchao Qiu has nothing to disclose.
Phillip Phan	Mr. Phan has nothing to disclose.
Areeba Nisar, MD	Dr. Nisar has nothing to disclose.
Mahdi Alizadeh, PhD	Dr. Alizadeh has nothing to disclose.
Devon Middleton, PhD	Dr. Middleton has received intellectual property interests from a discovery or technology relating to health care.
Feroze Mohamed, PhD	The institution of Prof. Mohamed has received research support from NIH. Prof. Mohamed has received intellectual property interests from a discovery or technology relating to health care. Prof. Mohamed has received publishing royalties from a publication relating to health care.
Joga Chaganti	Joga Chaganti has nothing to disclose.
Kiran Talekar	An immediate family member of Kiran Talekar has received personal compensation for serving as an employee of Verismo. An immediate family member of Kiran Talekar has received personal compensation for serving as an employee of GSK Pharmaceuticals. An immediate family member of Kiran Talekar has stock in GSK. The institution of Kiran Talekar has received research support from NIH. The institution of Kiran Talekar has received research support from Gates Foundation. An immediate family member of Kiran Talekar has received intellectual property interests from a discovery or technology relating to health care.
Prabath Mondel	Prabath Mondel has nothing to disclose.
Scott Faro	Scott Faro has nothing to disclose.
Syed Ahmed, DO	Dr. Ahmed has nothing to disclose.
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Matthew Varon, MD	Dr. Varon has nothing to disclose.
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Katheryn Lillig, BS, CCRP	Mrs. Lillig has nothing to disclose.
Constantine Farmakidis, MD, FAAN	Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Andrew Heim	Andrew Heim has nothing to disclose.
Long F. Davalos, MD	Dr. Davalos has nothing to disclose.
Mohamed Alsaied	Dr. Alsaied has nothing to disclose.
Abdelrahman M. Elettreby	Dr. Elettreby has nothing to disclose.
Ahmed A. Abo Elnaga	Dr. Abo Elnaga has nothing to disclose.
Ibrahim Serag, MD	Dr. Serag has nothing to disclose.
Daniel W. Saukkonen	Mr. Saukkonen has nothing to disclose.
Mansi Karwa, MS	Ms. Karwa has nothing to disclose.
Diane Maimonis	Ms. Maimonis has nothing to disclose.
John Dickson, MD, PhD	Dr. Dickson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for I-Mab Biopharma.
Liliana A. Ramirez-Gomez, MD, FAAN	The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH.
Kirk R. Daffner, MD, FAAN	The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
Maria Teresa Gomez-Isla, MD	No disclosure on file
Michael G. Erkkinen, MD	Dr. Erkkinen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen.
Sean Montgomery, MD	Dr. Montgomery has nothing to disclose.
Scott M. Belliston, DO	Dr. Belliston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Khushi Patel, MD	Miss Patel has nothing to disclose.
Pratit D. Patel, MD	Dr. Patel has nothing to disclose.
Maria Gilli, RN	Mrs. Gilli has nothing to disclose.
Dustin Rochestie, DO	Dr. Rochestie has nothing to disclose.
Geraldine Sanfillippo, RN	Mrs. Sanfillippo has nothing to disclose.
Yuxiang Zhou, PhD	Dr. Zhou has nothing to disclose.
Celine S. Dumitrascu, Student	Miss Dumitrascu has nothing to disclose.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Aaron F. Struck, MD	The institution of Dr. Struck has received research support from Ceribell.
M. B. Westover, MD, PhD	Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Mariel Kalkach Aparicio, MD	Mariel Kalkach Aparicio, MD has nothing to disclose.
Masoom J. Desai, MD	Dr. Desai has nothing to disclose.
Justine E. Cormier, MD	Dr. Cormier has nothing to disclose.
Irfan S. Sheikh, MD	Dr. Sheikh has nothing to disclose.
Jorge A. Cespedes	Mr. Cespedes has nothing to disclose.
Kaileigh Gallagher	Ms. Gallagher has nothing to disclose.
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Amanda Jagolino-Cole, MD, FAAN	Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� - Neurology Clinical Practice Journal. .
Kenneth Pham	Mr. Pham has nothing to disclose.
Tamia Garrett, MS	Miss Garrett has nothing to disclose.
Cristy Autry, RN,BSN	Mrs. Autry has nothing to disclose.
Melanie Jagolino	Mrs. Jagolino has nothing to disclose.
Mark Martyn	Mr. Martyn has received personal compensation in the range of $50,000-$99,999 for serving as a Battalion Chief of EMS with City of Victoria - Victoria Fire Dept.
Deepa Dongarwar	Deepa Dongarwar has nothing to disclose.
Faizan Shahzad	Mr. Shahzad has nothing to disclose.
Aamna Z. Khan, Medical student	Miss Khan has nothing to disclose.
Zainab .. Waqar, MBBS	Dr. Waqar has nothing to disclose.
Eman Hafeez, Medical Student (MBBS)	Ms. Hafeez has nothing to disclose.
Muaz Ali, MD	Dr. Ali has nothing to disclose.
Besher Shami, MD	Dr. Shami has nothing to disclose.
Farhan Shahzad	Dr. Shahzad has nothing to disclose.
Muhammad Tayyab Muzaffar Chaychi, MD	Muhammad Tayyab Muzaffar Chaychi, MD has nothing to disclose.
Luana M. Makita	Miss Makita has nothing to disclose.
Oguz Kagan Sahin, MD	Dr. Sahin has nothing to disclose.
Murilo Cruccioli	Mr. Cruccioli has nothing to disclose.
Letícia R. Campos, Medical student	Miss Campos has nothing to disclose.
Nathalia Gregorio Barbosa Tavares, MD	Dr. Gregorio Barbosa Tavares has nothing to disclose.
Pedro H. Teixeira	Mr. Teixeira has nothing to disclose.
Irena Dujmovic Basuroski, MD, PhD	The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund. The institution of Dr. Dujmovic Basuroski has received research support from CorEvitas, LLC. The institution of Dr. Dujmovic Basuroski has received research support from Novartis. The institution of Dr. Dujmovic Basuroski has received research support from Ad Scientiam. Dr. Dujmovic Basuroski has received personal compensation in the range of $0-$499 for serving as a Travel -related expenses to attend clinical trial investigator meeting with Novartis. Dr. Dujmovic Basuroski has received personal compensation in the range of $500-$4,999 for serving as a International Clinical Consortium Member, Travel -related expenses to attend the meeting with The Guthy-Jackson Charitable Foundation.
Winnie Lau, MD	The institution of Dr. Lau has received research support from International Neuropalliative Care Society. The institution of Dr. Lau has received research support from Pfizer Corporation.
Dena Williams, DO	Dr. Williams has nothing to disclose.
Monica M. Diaz, MD, MS	The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.
Catherine Garcia, MD	Dr. Garcia has nothing to disclose.
Niharika Reddy, MD	Dr. Reddy has nothing to disclose.
Julia B. Magsam, Undergraduate student	Ms. Magsam has nothing to disclose.
John L. Villano, MD, PhD	Dr. Villano has nothing to disclose.
Nicholas Liquigli, DO	Dr. Liquigli has nothing to disclose.
Jason T. Schick, DO	Dr. Schick has nothing to disclose.
Bobbi Thursam, MD	Dr. Thursam has nothing to disclose.
Christopher Gilbert, MD	Dr. Gilbert has nothing to disclose.
Bradley Haveman-Gould, PA	Mr. Haveman-Gould has nothing to disclose.
Muhammad Farooq, MD	Dr. Farooq has nothing to disclose.
Tiffany Cao, Medical Student	Ms. Cao has nothing to disclose.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Ayushi D. Balan	Miss Balan has nothing to disclose.
Annika Anderson	Miss Anderson has nothing to disclose.
Stephanie Hsu	Stephanie Hsu has nothing to disclose.
Maria K. Houtchens, MD	Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech. The institution of Dr. Houtchens has received research support from Novartis.
Min Ji Kim, BA	Ms. Kim has nothing to disclose.
Paulette D. Chavez	Miss Chavez has nothing to disclose.
Ricardo J. Moran	Mr. Moran has nothing to disclose.
Bryan J. Cedeño	Mr. Cedeño has nothing to disclose.
Ronald Hernandez	Mr. Hernandez has nothing to disclose.
Pamela A. Moran	Miss Moran has nothing to disclose.
Martin S. Guevara, Sr., MD	Mr. Guevara has nothing to disclose.
Meylin M. Alava	Miss Alava has nothing to disclose.
Allyson M. Morales, Sr., MD	Dr. Morales has nothing to disclose.
Justin S. Moon, MD, FAAN	The institution of Dr. Moon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Moon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Moon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Moon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Moon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Moon has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Moon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Averitas. Dr. Moon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Copic .
Alyanna Ferrer, Medical Assistant	Ms. Ferrer has nothing to disclose.
Tejas S. Lal	Mr. Lal has nothing to disclose.
Mahima Sriram	Miss Sriram has nothing to disclose.
Muddana Nikhilesh	Muddana Nikhilesh has nothing to disclose.
Pula Rohan	Pula Rohan has nothing to disclose.
sudeep reddy jinna	sudeep reddy jinna has nothing to disclose.
Sudheeran Kannoth	The institution of Sudheeran Kannoth has received research support from ICMR.
Vivek K. Nambiar, DM	Dr. Nambiar has nothing to disclose.
Siby Gopinath	No disclosure on file
Udit U. Saraf, MD, MBBS	Dr. Saraf has nothing to disclose.
Gopikrishnan Unnikrishnan	Gopikrishnan Unnikrishnan has nothing to disclose.
Anand Kumar, MD	Dr. Kumar has nothing to disclose.
Abish Sudhakar, Research Coordinator	Mr. Sudhakar has nothing to disclose.
Annamma Mathai	Annamma Mathai has nothing to disclose.
Meena Thevarkalam	Meena Thevarkalam has nothing to disclose.
Suprabha Panicker, SCIENTIFIC ASSISTANT	Mrs. Panicker has nothing to disclose.
Yuri G. de Souza	Mr. de Souza has nothing to disclose.
Marianna Leite	Miss Leite has nothing to disclose.
Sophia Toscano	Ms. Toscano has nothing to disclose.
Giovanni G. Berton	The institution of Mr. Berton has received research support from CRUI-CARE Agreement.
Gabriela D. Carolino	Miss Carolino has nothing to disclose.
Heloisa N. Omuro, Ms	Miss Omuro has nothing to disclose.
Abner Lucas B. De Souza, Sr., MS	Mr. De Souza has nothing to disclose.
Evelyn de d. Pacheco, MD	Dr. Pacheco has nothing to disclose.
John M Hourihane	No disclosure on file
Spencer Maranto	Mr. Maranto has nothing to disclose.
Karen Stephenson	Ms. Stephenson has nothing to disclose.
Azka Shaikh, MD	Dr. Shaikh has nothing to disclose.
Amit Kandel, MD	Dr. Kandel has nothing to disclose.
Aya A. Ouf, MBBS	Dr. Ouf has nothing to disclose.
Christine F. Spatacean	Miss Spatacean has nothing to disclose.
Alex Schatzki-Lumpkin	Mr. Schatzki-Lumpkin has nothing to disclose.
Annalise Bracher	Ms. Bracher has nothing to disclose.
Izayadeth Jennings, MD	Dr. Jennings has nothing to disclose.
Renae L. Dorrity, MD	Dr. Dorrity has nothing to disclose.
Srikar V. Vegesna, MD	Dr. Vegesna has nothing to disclose.
Joyce K. Lee-Iannotti, MD, FAAN	Dr. Lee-Iannotti has nothing to disclose.
Sanjay B. Kaji, MD	Dr. Kaji has nothing to disclose.
Rachel Fisher	Miss Fisher has nothing to disclose.
Paweł M. Łajczak	Mr. Lajczak has nothing to disclose.
Ayesha Ayesha	Miss Ayesha has nothing to disclose.
Sriharsha Koduru, MBBS	Dr. Koduru has nothing to disclose.
Heloísa C. Brito, Medical Student	Miss Brito has nothing to disclose.
Júlia dos Santos Monteiro, MS	Dr. dos Santos Monteiro has nothing to disclose.
Milena Ramos Tomé, Medical student	Ms. Ramos Tomé has nothing to disclose.
Giovana S. Kojima	Mrs. Kojima has nothing to disclose.
Mariana Oliveira, MD	Miss Oliveira has nothing to disclose.
Kotaro Tsutsumi, MD	Dr. Tsutsumi has nothing to disclose.
Shenyu Tong	No disclosure on file
Brian Jung, MD	Dr. Jung has nothing to disclose.
Yama Akbari, MD, PhD	Dr. Akbari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for AZ Injury Law. The institution of Dr. Akbari has received research support from NIH. The institution of Dr. Akbari has received research support from Hamamatsu Photonics KK. Dr. Akbari has received intellectual property interests from a discovery or technology relating to health care.
Sara J. Stern-Nezer, MD	Dr. Stern-Nezer has nothing to disclose.
Cyrus K. Dastur, MD	Dr. Dastur has nothing to disclose.
Wengui Yu, MD, PhD	Dr. Yu has nothing to disclose.
Walter W. Valesky, Jr., MD	Dr. Valesky has nothing to disclose.
Sonja Darwish, MD	Dr. Darwish has nothing to disclose.
Michelle F. Goodwin, MD	Dr. Goodwin has nothing to disclose.
Jeff W. Chen, MD, PhD	The institution of Dr. Chen has received research support from Mitsubishi.
Michael Lekawa	No disclosure on file
Areg Grigorian	Areg Grigorian has nothing to disclose.
Jeffry Nahmias, MD, MHPE	Dr. Nahmias has nothing to disclose.
Kurt Y. Qing, MD, PhD	Dr. Qing has nothing to disclose.
Patrick M. Chen, MD	Dr. Chen has nothing to disclose.
Patrick Callaghan, MD	Dr. Callaghan has nothing to disclose.
Richard Hartfield, DO	Dr. Hartfield has nothing to disclose.
Satabdi Chakrabarti Pulakanti, DO	Dr. Chakrabarti Pulakanti has nothing to disclose.
Xin Zhou, MD	An immediate family member of Dr. Zhou has received personal compensation for serving as an employee of PTC Therapeutics . An immediate family member of Dr. Zhou has or had stock in PTC Therapeutics.
Lina Al Qadi	Miss Al Qadi has nothing to disclose.
Ludivine Chamard Witkowski	Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck Serono. The institution of Ludivine Chamard Witkowski has received research support from CFMNB. The institution of Ludivine Chamard Witkowski has received research support from Cantrain.
Dominique Comeau	Dominique Comeau has nothing to disclose.
Véronique Landry, MD	Dr. Landry has received personal compensation in the range of $50,000-$99,999 for serving as a Trainee in the Royal College of Physicians and Surgeons of Canada : Clinicial-Investigator Program with Vitalité Health Network.
Robert Laforce, Jr., MD, PhD	Dr. Laforce has nothing to disclose.
Emilie Laplante, PsyD	Dr. Laplante has nothing to disclose.
Mahée Cote, Medical Student	Miss Cote has nothing to disclose.
Luc Boudreau, PhD	Dr. Boudreau has nothing to disclose.
Gilles A. Robichaud, PhD	Prof. Robichaud has stock in Agrogene solutions Inc . The institution of Prof. Robichaud has received research support from Canadian cancer society .
Josiane Stadler	Ms. Stadler has nothing to disclose.
Marie-Claire Losier, DPs, LPsych	Dr. Losier has nothing to disclose.
Carlos Guevara-Oliva	No disclosure on file
Eduardo Villa	Eduardo Villa has nothing to disclose.
Antonio Piottante, MD	Dr. Piottante has nothing to disclose.
Gonzalo Carrasco Avino	Gonzalo Carrasco Avino has nothing to disclose.
Rodrigo Naves	Rodrigo Naves has nothing to disclose.
Enzo Von Quednow, Jr., MD	Dr. Von Quednow has nothing to disclose.
Luini D. Garcia-Quiroa	Mr. Garcia-Quiroa has nothing to disclose.
Alejandra Duque Ramirez, MD	Dr. Duque Ramirez has nothing to disclose.
Laura Dresser, MD	Dr. Dresser has nothing to disclose.
Amanda F. Abuaf, MD	Dr. Abuaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Adil Javed, MD, PhD	The institution of Dr. Javed has received research support from Genentech Roche .
Anthony Hong, MD	Dr. Hong has nothing to disclose.
Ocilio R. Goncalves, MS	Mr. Goncalves has nothing to disclose.
Ana Santos, MD	Ms. Santos has nothing to disclose.
Marcio Y. Ferreira, MD	Dr. Ferreira has nothing to disclose.
Victor G. Soares, MS	Mr. Soares has nothing to disclose.
Luiza G. Schmitt	No disclosure on file
Savio Batista, MD	Mr. Batista has nothing to disclose.
Luis O. Nogueira, medical student	Mr. NOGUEIRA has nothing to disclose.
João Victor Araújo de Oliveira, MD	Mr. Araújo de Oliveira has nothing to disclose.
João de Deus Costa Alves	No disclosure on file
Kelson J. Almeida, PhD	Prof. Almeida has nothing to disclose.
Marina Vilardo	Miss Vilardo has nothing to disclose.
Haris Sharieff, BS	Mr. Sharieff has nothing to disclose.
Fahd Sultan, MD	Dr. Sultan has nothing to disclose.
Hassan Imtiaz, MD	Dr. Imtiaz has nothing to disclose.
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Casey S. Albin, MD, FAAN	Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from ��ɫ��. Dr. Albin has received publishing royalties from a publication relating to health care.
Deanna Saylor, MD, MHS	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from ��ɫ��. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and ��ɫ��al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Michael P. Stanley, MD	Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Consultant for Roon. Dr. Stanley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Stanley has stock in Roon. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a writer at large with WBUR/Cognoscenti . Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Poet with Writing the Land. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a writer at large with Psyche. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Writer at large with Wall Street Journal.
Aileen Antonio, MD, FAAN	Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. An immediate family member of Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Giamarco, Mullins & Horton PC. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. Dr. Antonio has received research support from ��ɫ��.
Alison L. Christy, MD, PhD, FAAN	Dr. Christy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity. Dr. Christy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishing. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. The institution of Dr. Christy has received research support from Biohaven. The institution of Dr. Christy has received research support from Novartis / Amgen. The institution of Dr. Christy has received research support from Eli Lilly. The institution of Dr. Christy has received research support from Abbvie.
Elizabeth A. Coon, MD, FAAN	Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Micah Etter, MD	Dr. Etter has nothing to disclose.
Matthew Roberts, MD	Dr. Roberts has nothing to disclose.
Zain Guduru, MD, FAAN	Dr. Guduru has nothing to disclose.
Nina Y. Riggins, MD, FAAN	Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Gerson Lehrman Group . Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeurologyLive. The institution of Dr. Riggins has received research support from ElectroCore (GammaCore). The institution of Dr. Riggins has received research support from Miles for Migraine. The institution of Dr. Riggins has received research support from Eli Lilly. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has a non-compensated relationship as a PI on research study with TheraSpecs that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Advisory Board with NeurologyLive that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Member of the Board with Miles for Migraine that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI in the study which used sphenocath device with Dolor Technologies that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI with Theranica that is relevant to AAN interests or activities.
Michael Kentris, DO	Dr. Kentris has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��.
Esteban Cheng-Ching, MD	Dr. Cheng-Ching has received publishing royalties from a publication relating to health care.
Celia Fung, MD	Dr. Fung has nothing to disclose.
Jean-Luc Rolland, MD	Mr. Rolland has nothing to disclose.
Morgan Prust, MD	Dr. Prust has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Edelman & Edelman, PC.
Sarah Wahlster, MD	Dr. Wahlster has nothing to disclose.
Sarah Livesay, RN, NP, DNP	Dr. Livesay has received personal compensation for serving as an employee of Lombardi Hill/stroke challenges LLC. Dr. Livesay has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Neurocritical Care Society. Dr. Livesay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Baptist Health South Florida . Dr. Livesay has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Scott and Patton. Dr. Livesay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for PCVA Law .
Aimee M. Aysenne, MD, MPH	Dr. Aysenne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Aysenne has received stock or an ownership interest from Teledoc. Dr. Aysenne has received stock or an ownership interest from Pfizer.
Meron Gebrewold, MD	Dr. Gebrewold has nothing to disclose.
Mundih N. Njohjam, MD	Dr. Njohjam has nothing to disclose.
Yasser B. Abulhasan, MD	Dr. Abulhasan has nothing to disclose.
Mustapha M. Abdullahi, MD	Dr. Abdullahi has nothing to disclose.
Hanna D. Belay, MD	Dr. Belay has nothing to disclose.
Leila Modupe Ilupeju, MBChB, MSc (Oxon)	Miss Ilupeju has nothing to disclose.
Ismail Hassan, MBBS	Dr. Hassan has nothing to disclose.
Halima Moji Salisu-Kabara, PhD, RN	Dr. Salisu-Kabara has nothing to disclose.
Vittal Byabashaija, RN	Mr. Byabashaija has nothing to disclose.
Gambo Isa Muhammad, RN	Mr. Isa Muhammad has nothing to disclose.
Susan Yeager, NP	Dr. Yeager has nothing to disclose.
Aisha Rizwan Ahmed, MBBS	Dr. Rizwan Ahmed has nothing to disclose.
Natalia Arturo, MD	Ms. Arturo has nothing to disclose.
Thomas C. Varkey, MD	Dr. Varkey has nothing to disclose.
Paweł Chochoł, MD	Mr. Chochol has nothing to disclose.
Michael J. Smith, MD	Dr. Smith has nothing to disclose.
Alyssa R. Redai, MD	Ms. Redai has nothing to disclose.
Michael V. Robers, MD	Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation.
Ayushi Chugh, MD, FAAN	Dr. Chugh has nothing to disclose.
Fiona M. Hanly-Jorda	Miss Hanly-Jorda has nothing to disclose.
Sophie M. Bilik	Ms. Bilik has nothing to disclose.
Alfred J. Bilik, MD	Dr. Bilik has nothing to disclose.
Neil Patel	Mr. Patel has nothing to disclose.
Pallav Gandhi, PhD scholar	Mr. Gandhi has nothing to disclose.
Shital S. Panchal, PhD	The institution of Dr. Panchal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ProbioticSmart LLC. Dr. Panchal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Gujarat Technical University. The institution of Dr. Panchal has received research support from ProbioticSmart LL USA.
Dhanya Gorty, MBBS	Dr. Gorty has nothing to disclose.
Moneeb Nasir, MBBS	Dr. Nasir has nothing to disclose.
Kasun U. Athukoralage, MD, MBBS	Dr. No has nothing to disclose.
Plaxedes Rabvukwa, RN	Miss Rabvukwa has nothing to disclose.
Sarah E. Fuller, RN	Mrs. Fuller has nothing to disclose.
Laura Azzopardi, MD, PhD	Dr. Azzopardi has nothing to disclose.
Abhijit Chaudhuri, MD, PhD	Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Chaudhuri has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ.
Miriam Mattoscio, MD, PhD, FAAN	Dr. Mattoscio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK SERONO. Dr. Mattoscio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK SERONO.
Alex H. Panrudkevich	Ms. Panrudkevich has nothing to disclose.
Felipe Jones, MD	Dr. Jones has nothing to disclose.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Kamal Shouman, MD	Dr. Shouman has nothing to disclose.
Sarah E. Berini, MD	Dr. Berini has nothing to disclose.
Christopher Lamb, MD	Dr. Lamb has received research support from Immunovant, Inc.
Jackie Jacobi	No disclosure on file
Nathan P. Staff, MD, PhD, FAAN	Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
JaNean Engelstad	JaNean Engelstad has nothing to disclose.
Martha Grogan, MD	Dr. Grogan has nothing to disclose.
Angela Dispenzieri, MD	Prof. Dispenzieri has nothing to disclose.
Julie A. Khoury, MD	Dr. Khoury has nothing to disclose.
Elizabeth A. Mauricio, MD, FAAN	Dr. Mauricio has nothing to disclose.
Michelle L. Mauermann, MD, FAAN	The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Marcus Vinicius R. Pinto, MD	Dr. Pinto has nothing to disclose.
Jashank A. Parwani, MBBS	Dr. Parwani has nothing to disclose.
Nicki Karimi-Mostowfi, MD	Miss Karimi-Mostowfi has nothing to disclose.
Akshay Arora, MS	Mr. Arora has nothing to disclose.
Briget da Graca, JD, MS	Ms. da Graca has nothing to disclose.
Monica M. Bennett, PhD	Dr. Bennett has nothing to disclose.
Cynthia Sunderman, RN, MSN	Ms. Sunderman has nothing to disclose.
John Venditto	John Venditto has received personal compensation for serving as an employee of AstraZeneca . John Venditto has stock in AstraZeneca .
Muhammad S. Khan, MD	Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer.
Jason ettlinger	Mr. ettlinger has nothing to disclose.
Elisa L. Priest, DrPH	The institution of Dr. Priest has received research support from AstraZeneca. The institution of Dr. Priest has received research support from Boehringer Ingelheim. The institution of Dr. Priest has received research support from CSL Vifor. The institution of Dr. Priest has received research support from Owkin. The institution of Dr. Priest has received research support from Lyda Hill Foundation.
Kendall P. Hammonds, MPH	Ms. Hammonds has nothing to disclose.
Mia Papas, PhD	Dr. Papas has received personal compensation for serving as an employee of AstraZeneca. Dr. Papas has stock in AstraZeneca.
Robert Gottlieb, MD	Dr. Gottlieb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Gottlieb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Gottlieb has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals.
Cesar Jara Silva Acosta, DO	Dr. Jara Silva Acosta has nothing to disclose.
Solomon Nittala, DO	Dr. Nittala has nothing to disclose.
Mitali Chansarkar, MD	Dr. Chansarkar has nothing to disclose.
Larissa Diaz Fajardo, MD	Dr. Diaz Fajardo has nothing to disclose.
Fernanda C. Pereira, MD	Mrs. Pereira has nothing to disclose.
Sha Jing	Dr. Jing has nothing to disclose.
Na Zhao	Ms. Zhao has nothing to disclose.
Kaidierya Aimudula, MBBS	Ms. Aimudula has nothing to disclose.
Maynur Mamat	No disclosure on file
hongyan li, MD	Dr. li has nothing to disclose.
Emily Dvorak	Ms. Dvorak has nothing to disclose.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Emanuelly L. Barbosa	Ms. Barbosa has nothing to disclose.
Pablo V. Feitoza, MD, PhD	Prof. Feitoza has nothing to disclose.
Yuan Cheng, PhD	Dr. Cheng has nothing to disclose.
Alvin P. Singh, MD	Mr. Singh has nothing to disclose.
Katherine Fu, MD	Dr. Fu has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��: Neurology Journal . Dr. Fu has received research support from ��ɫ��. Dr. Fu has received personal compensation in the range of $0-$499 for serving as a Edmond J. Safra Fellowship Reviewer with The Michael J. Fox Foundation.
Adnan Husein, MD	Dr. Husein has nothing to disclose.
Adrienne M. Keener, MD	Dr. Keener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie.
Ryan Nguyen, MD	Dr. Nguyen has nothing to disclose.
David B. Burkholder, MD, FAAN	The institution of Dr. Burkholder has received research support from Longboard pharmaceuticals.
Christina Shupe	Ms. Shupe has nothing to disclose.
Kaitlin Chung	Kaitlin Chung has nothing to disclose.
Jennifer Weinstein	Jennifer Weinstein has nothing to disclose.
Charlotte Irwin	Ms. Irwin has nothing to disclose.
Preshetha Kanagaiah	Miss Kanagaiah has nothing to disclose.
Charlotte Engebrecht	Ms. Engebrecht has nothing to disclose.
Judith Monickaraj, MS	Ms. Monickaraj has nothing to disclose.
Sachi Kalra	Miss Kalra has nothing to disclose.
Autumn Mains, RN, MSN	Mrs. Mains has nothing to disclose.
Glen A. Cook, Jr., MD, FAAN	Dr. Cook has stock in Aspire Biopharma. An immediate family member of Dr. Cook has stock in Aspire Biopharma.
Mark C. Haigney, MD	Dr. Haigney has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ICON Clinical Research LLC. Dr. Haigney has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Noninvasive. Electrocardiology. Dr. Haigney has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for JOSEPH GREENWALD & LAAKE, P.A.. The institution of Dr. Haigney has received research support from Defense Health Administration.
Chad R. Heatwole, MD, FAAN	Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Legal Med. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $0-$499 for serving as a Consultant for Iris. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for New York Central Mutual. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Penn Prop and Gas. The institution of Dr. Heatwole has received research support from Department of Defense. The institution of Dr. Heatwole has received research support from Novartis. The institution of Dr. Heatwole has received research support from MJFF. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from University of Miami. The institution of Dr. Heatwole has received research support from MDA. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
Charles E. Argoff, MD	Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for XGene. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Colllegium. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Argoff has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Scilex. The institution of Dr. Argoff has received research support from Lilly. The institution of Dr. Argoff has received research support from Lundbeck. The institution of Dr. Argoff has received research support from Abbvie. The institution of Dr. Argoff has received research support from Vertex. Dr. Argoff has received publishing royalties from a publication relating to health care.
Steven P. Herzog, MD	Dr. Herzog has nothing to disclose.
Ryan M. Smith, DO, FAAN	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Fawad Khan, MD	Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Khan has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epitel. Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Khan has received research support from Marinus. The institution of Dr. Khan has received research support from UCB. The institution of Dr. Khan has received research support from Teva. Dr. Khan has a non-compensated relationship as a Ad board with Louisiana State Medical Advisory Board that is relevant to AAN interests or activities.
Melissa Bendayan, MD	Dr. Bendayan has nothing to disclose.
Helene Rubeiz, MD	Dr. Rubeiz has nothing to disclose.
Josephe Archie Honorat, MD, PhD	Dr. Honorat has nothing to disclose.
Amy Espinal, MD	Dr. Espinal has nothing to disclose.
Okker Verhagen Metman, DO	Dr. Verhagen Metman has nothing to disclose.
Lemuel Hope S. Galindo	Dr. Galindo has nothing to disclose.
Julia Paula F. Alcantara, MD	Ms. Alcantara has nothing to disclose.
Emmanuel C. Mantilla, MD	Dr. Mantilla has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Vandana Gupta, MSc	Ms. Gupta has nothing to disclose.
Carole Drexel	Carole Drexel has nothing to disclose.
Theresa Bartolotta, PhD	Dr. Bartolotta has received personal compensation in the range of $0-$499 for serving as a Consumer Reviewer with General Dynamics. Dr. Bartolotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with International Rett Syndrome Foundation.
Henry Hasson, MD	Dr. Hasson has nothing to disclose.
David N. Lieberman, MD, PhD	Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene.
Dallas Armstrong, MD	The institution of Dr. Armstrong has received research support from Taysha.
Karen C. Keough, MD	Dr. Keough has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with UCB. Dr. Keough has received personal compensation in the range of $50,000-$99,999 for serving as a Speaker with Jazz Pharmaceuticals. Dr. Keough has received personal compensation in the range of $50,000-$99,999 for serving as a Speaker with SKLSI . Dr. Keough has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with LivaNova.
Amitha Ananth, MD	Dr. Ananth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Therapeutics. The institution of Dr. Ananth has received research support from Acadia Pharmaceuticals.
Jieun Kang, MD	Dr. Kang has nothing to disclose.
Lealani M. Acosta, MD, MPH, FAAN	Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences.
Anne Chen	Ms. Chen has nothing to disclose.
Jennifer Du	Miss Du has nothing to disclose.
Andrea Nuñez de Caceres Garcia, MD	Miss Nuñez de Caceres Garcia has received research support from Secretaría de Salud.
David Medina Julio, MD	Dr. Medina Julio has received research support from CONAHCYT.
Carlos Cantu, MD, MSc	Dr. Cantu has nothing to disclose.
Rogelio Dominguez-Moreno, MD	Dr. Dominguez-Moreno has nothing to disclose.
Osmar F. Albores, MD	Dr. Albores has nothing to disclose.
Alvaro Calderon-Cantu, MD	Dr. Calderon-Cantu has received research support from Secretaria de Salud.
Ximena A. García-Velazquez	Miss García-Velazquez has nothing to disclose.
Michelle A. Coutiño Díaz, MD	Dr. Coutiño Díaz has nothing to disclose.
Samuel Luca R. Pinheiro	Mr. Pinheiro has nothing to disclose.
Artur Menegaz de Almeida, MS	Mr. Menegaz de Almeida has nothing to disclose.
Aminah A. Lima	Miss Lima has nothing to disclose.
Alexia C. Oliveira Rocha	Miss Oliveira Rocha has nothing to disclose.
Felipe A. de Paiva	Mr. de Paiva has nothing to disclose.
Rafael L. Nohmi, MD	Mr. Nohmi has received research support from CNPQ - PIBIC.
Danilo M. Ribeiro	Mr. Ribeiro has nothing to disclose.
Théo J. Tozzo	Mr. Tozzo has nothing to disclose.
Thiago S. Martins, Study	Hon. Martins has nothing to disclose.
Caio P. Cavalcante, Sr., MS	Mr. Cavalcante has nothing to disclose.
Nuris M. Torres Argota, Sr.	Dr. Torres Argota has nothing to disclose.
Helen C. Beckert	Miss Beckert has nothing to disclose.
Larissa E. Tanimoto, student	Miss Tanimoto has nothing to disclose.
Andressa G. Cardoso, Medicine student	Mrs. Cardoso has nothing to disclose.
Francisco Jose Germano Hennemann	Mr. Germano Hennemann has nothing to disclose.
Paulo M. Cruz, Sr., Student	Mr. Cruz has nothing to disclose.
Hamilton Roberto Moreira de Oliveira Carrico	Mr. Roberto Moreira de Oliveira Carrico has nothing to disclose.
Diego Delgado, MD	Prof. Delgado has nothing to disclose.
Christopher Venner, MD	Dr. Venner has nothing to disclose.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Donna Reece	No disclosure on file
Steven K. Baker, MD	Dr. Baker has nothing to disclose.
Victoria Hodgkinson	No disclosure on file
Margot Davis, MD	Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. The institution of Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. The institution of Dr. Davis has received research support from Pfizer.
Nowell M. Fine, MD	Dr. Fine has nothing to disclose.
Rami Massie, MD	Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gowlingwlg. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Pfizer. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Argenx.
Alexandra R. Balshi	Ms. Balshi has nothing to disclose.
Jacob A. Sloane, MD, PhD	Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Sloane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
John Dempsey, BA	Mr. Dempsey has nothing to disclose.
Saanvi Nimma, Intern	Miss Nimma has nothing to disclose.
Helen A. Lutz	Miss Lutz has nothing to disclose.
Angela Scott, CRC	Ms. Scott has nothing to disclose.
Manesa Mosley, Leqembi Coordinator	Ms. Mosley has nothing to disclose.
Meghan Kodsi	Ms. Kodsi has nothing to disclose.
Emma Yellin, MD	Dr. Yellin has nothing to disclose.
Sofia Constantinescu, BS	Ms. Constantinescu has nothing to disclose.
Rachel Kitagawa	Ms. Kitagawa has nothing to disclose.
Sophia E. DeLuca, BA	Miss DeLuca has received personal compensation for serving as an employee of Wilson Center Maternal Health Initiative. Miss DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Khushi Baby.
Lauren H. Sansing, MD	Dr. Sansing has nothing to disclose.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Emilie Egger, PhD	Dr. Egger has nothing to disclose.
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Rachel Forman, MD	Dr. Forman has nothing to disclose.
Varsha S. Murthy	Ms. Murthy has nothing to disclose.
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Iqra Shahid, MBBS	Dr. Shahid has nothing to disclose.
Fatima Shahid	FATIMA SHAHID has nothing to disclose.
Mahnoor Fatima, MBBS	Miss Fatima has nothing to disclose.
Ahmed Raza	Ahmed Raza has nothing to disclose.
Mohammad Ammar Ur Rahman, MBBS	Dr. Ammar Ur Rahman has nothing to disclose.
Luqman Munir	Mr. Munir has nothing to disclose.
Manon Auffret, PhD, PharmD, DAAN	Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aguettant. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aguettant. The institution of Dr. Auffret has received research support from Oxylis Medical. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care.
Marc Verin	Mr. Verin has nothing to disclose.
Xiaoqian Song	Ms. Song has nothing to disclose.
Jingjiao Chen	No disclosure on file
Xueping Zheng	No disclosure on file
Victor Arthur A. Ohannesian, MS	Mr. Ohannesian has nothing to disclose.
Henrique G. Maia, MS	Mr. Maia has nothing to disclose.
Luis Paleare, MS	Mr. Paleare has nothing to disclose.
Tarsis C. Mendes, Medical Student	Mr. Mendes has nothing to disclose.
Kayla Johnson, PharmD	Dr. Johnson has nothing to disclose.
MORTEZA KAVEH, Pharmacy student	Mr. KAVEH has nothing to disclose.
Sabrina Livezey, PharmD	Dr. Livezey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva.
Ryan Moore, MS	Mr. Moore has nothing to disclose.
Katie Cruchelow, PhD	Dr. Cruchelow has nothing to disclose.
Thomas Scheinok, MD	Dr. Scheinok has nothing to disclose.
Jeroen Van Schependom	Jeroen Van Schependom has nothing to disclose.
Dimitri De Bundel	Dimitri De Bundel has nothing to disclose.
Luiz Henrique Medeiros Geraldo, MD, PhD	Dr. Medeiros Geraldo has nothing to disclose.
Melanie Li, MD	Dr. Li has nothing to disclose.
Lauren Brandes, MD	Dr. Brandes has nothing to disclose.
Andrea Loggini, MD, MPH MBA	Dr. Loggini has nothing to disclose.
Jonatan Hornik, MD	Dr. Hornik has nothing to disclose.
Jessie A. Henson, RN	Mrs. Henson has nothing to disclose.
Alejandro Hornik, MD	Dr. Hornik has nothing to disclose.
Karam Dallow, MD	Dr. Dallow has nothing to disclose.
Amber Schwertman	Mrs. Schwertman has nothing to disclose.
Julie Wesler, RN	Ms. Wesler has nothing to disclose.
Roxanne F. Houle	Mrs. Houle has nothing to disclose.
Dean Houle	Mr. Houle has nothing to disclose.
Sophia D. Kocher	Ms. Kocher has nothing to disclose.
Catherine Stratton, MPH	Miss Stratton has nothing to disclose.
Shivika Chandra, MD, FAAN	The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in ��ɫ�� Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Sushanth R. Aroor, MD	Dr. Aroor has stock in Gravity.
Dana Woodward, EMTLP, AAS	Mr. Woodward has nothing to disclose.
Brandy Davis, EMT-LP	Ms. Davis has nothing to disclose.
Yasmin P. Silva, MD	Dr. Silva has nothing to disclose.
Zain U. Abideen, MBBS	Dr. Abideen has nothing to disclose.
Hassan Waseem	Hassan Waseem has nothing to disclose.
Jamir Pitton Rissardo, MD	Dr. Pitton Rissardo has nothing to disclose.
Sania Aimen, MBBS	Dr. Aimen has nothing to disclose.
Ana Leticia Fornari Caprara, MD	Dr. Fornari Caprara has nothing to disclose.
Vishnu V. Byroju, MD	Dr. Byroju has nothing to disclose.
Hongxuan Wang	Mr. Wang has nothing to disclose.
Wanru Chen, MD	Dr. Chen has nothing to disclose.
Ying Peng, MD, PhD	Prof. Peng has nothing to disclose.
Sarah Levy, PhD	Dr. Levy has nothing to disclose.
Ilana B. Katz Sand, MD	The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with ��ɫ��.
Francesco La Rosa, PhD	Dr. La Rosa has nothing to disclose.
Robin Graney, Research Coordinator	Ms. Graney has nothing to disclose.
Raissa Aoun, MD	Dr. Aoun has nothing to disclose.
Stella Adetokunbo, MD	Dr. Adetokunbo has nothing to disclose.
Juan Solano, MD	Dr. Solano has nothing to disclose.
Saman Zafar, MD	Dr. Zafar has nothing to disclose.
Gabrielle Pancio	Gabrielle Pancio has nothing to disclose.
Johanne M. Kaplan, PhD	Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Ebrima Gibbs, Bsc, BMLSc, MSc	Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences.
Scott Napper, PhD	The institution of Dr. Napper has received research support from NSERC. The institution of Dr. Napper has received research support from Westin Foundation.
Erin Scruten, Research Technician	Ms. Scruten has nothing to disclose.
Juliane Coutts	Ms. Coutts has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ProMIS Neurosciences, Inc..
Neil Cashman, MD	Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IONIS. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care.
Haroon Shabbir	Mr. Shabbir has nothing to disclose.
Hussnain A. Osto, MBBS	Mr. Osto has nothing to disclose.
Amna B. Naeem, MBBS	Ms. Naeem has nothing to disclose.
Maheen Shaharyar, MBBS	Ms. Shaharyar has nothing to disclose.
Mubashir Pervez, MD, MBBS, FAAN	Dr. Pervez has nothing to disclose.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Daniel F. Sarpong	Dr. Sarpong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NYU Langone Medical Center. Dr. Sarpong has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association ATVB Journal.
Erica S. Spatz, MD	Dr. Spatz has nothing to disclose.
Lauren Nelson, MD	Dr. Nelson has nothing to disclose.
Emma M. Loebel, MD	Ms. Loebel has nothing to disclose.
Laura K. Stein, MD, MPH	The institution of Dr. Stein has received research support from American Heart Association.
Udeept Sindhu, MBBS	Dr. Sindhu has nothing to disclose.
Vineet Punia, MD	Dr. Punia has nothing to disclose.
Akshay Sharma	Akshay Sharma has nothing to disclose.
Ifrah Zawar, MD	The institution of Dr. Zawar has received research support from Alzheimer's association. The institution of Dr. Zawar has received research support from American epilepsy society . The institution of Dr. Zawar has received research support from NIH. The institution of Dr. Zawar has received research support from University of Virginia.
Michael P. Skolka, MD	Dr. Skolka has nothing to disclose.
Catherine Daley, MD	Dr. Daley has nothing to disclose.
Reena P. Thomas, MD, PhD, FAAN	The institution of Dr. Thomas has received research support from NIH. The institution of Dr. Thomas has received research support from California Institute of Regenerative Medicine. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care.
Devi Veerappan	Miss Veerappan has nothing to disclose.
Samantha Banks, MD	Dr. Banks has nothing to disclose.
Matthew R. Baker, PhD	Dr. Baker has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Fiona E. Permezel, MBBS	Dr. Permezel has nothing to disclose.
Lauren Jackson, MD	Dr. Jackson has nothing to disclose.
W. O. Tobin, PhD, MBBCh, BAO, FAAN	Dr. Tobin has received publishing royalties from a publication relating to health care.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Kai Miller	Kai Miller has nothing to disclose.
Bryan T. Klassen, MD	The institution of Dr. Klassen has received research support from Insightec.
Abdul Hannan Siddiqui, MBBS	Dr. Siddiqui has nothing to disclose.
Maria Roum Shahzada, MBBS	Dr. Roum Shahzada has nothing to disclose.
Saba Yaqoob, MBBS	Miss Yaqoob has nothing to disclose.
Zulfiqar H. Jogezai, MBBS, medical student	Mr. Jogezai has nothing to disclose.
Muhammad Moosa, MBBS	Dr. Moosa has nothing to disclose.
Asma Saif, MBBS	Miss Saif has nothing to disclose.
Muhammad Bilal, MBBS	Dr. Bilal has nothing to disclose.
Fizza Batool, MBBS	Ms. Batool has nothing to disclose.
Areeba Ehsan, MBBS	Dr. Ehsan has nothing to disclose.
Muhammad Shoaib, MBBS	Mr. Shoaib has nothing to disclose.
Malavika Rudrakumar	Miss Rudrakumar has nothing to disclose.
Aman M. Bhonsale, MBBS	Mr. Bhonsale has nothing to disclose.
Suhrud Panchawagh, MBBS	Dr. Panchawagh has nothing to disclose.
Sanskruti Mote	No disclosure on file
Anmol Kaur	Miss Kaur has nothing to disclose.
Ansh B. Gadhiya, Jr., MBBS	Mr. Gadhiya has nothing to disclose.
Mokshita R. Gundlagutta, MBBS	Miss Gundlagutta has nothing to disclose.
Himanshu Garg II, MBBS	Dr. Garg has nothing to disclose.
Khushi S. Sonchhatra, MBBS	Miss Sonchhatra has nothing to disclose.
Uditha S. Kolamala, MBBS	Miss Kolamala has nothing to disclose.
Anza Zahid, MD, MBBS	Dr. Zahid has nothing to disclose.
Jemynna H. Chua, MD	Dr. Chua has nothing to disclose.
Sanjiti Mirmire, MBBS	Dr. Mirmire has nothing to disclose.
Ashwin Achuthaprasad, MD	Dr. Achuthaprasad has nothing to disclose.
Ivo W. Tremont, MD, FAAN	Dr. Tremont has nothing to disclose.
Jorge Akira Valdivia Moriyama, MD	Dr. Valdivia Moriyama has nothing to disclose.
Valerie A. Block, DPTSc	Dr. Block has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Block has received research support from National MS Society.
Nikki Sisodia	Nikki Sisodia has nothing to disclose.
Kyra Henderson	Kyra Henderson has nothing to disclose.
Shane Poole	Shane Poole has nothing to disclose.
Rubí Angeles Alanya-Yangali	Miss Alanya-Yangali has nothing to disclose.
Luis Aguilar	Dr. Aguilar has nothing to disclose.
Luis S. Aguilar Alvarez	Dr. Aguilar Alvarez has nothing to disclose.
Jeremy J. Yauri Mamani, Student	Mr. Yauri Mamani has nothing to disclose.
Arpit Ramani	Arpit Ramani has nothing to disclose.
Beatriz Pereira Rios, MD	Dr. Pereira Rios has nothing to disclose.
Samuel Boes	Mr. Boes has nothing to disclose.
Solmaz Ramezani Hashtjin, MD	Dr. Ramezani Hashtjin has nothing to disclose.
Michael Usher	No disclosure on file
Chloe Botsford, MPH	Ms. Botsford has nothing to disclose.
Deborah Pestka	Deborah Pestka has nothing to disclose.
Joseph Koopmeiners	No disclosure on file
Tanvi Mehta, BA	Ms. Mehta has nothing to disclose.
Timothy Beebe	The institution of Timothy Beebe has received research support from NIH. The institution of Timothy Beebe has received research support from AHRQ.
Genevieve Melton-Meaux	Genevieve Melton-Meaux has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for American college of surgeons. Genevieve Melton-Meaux has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Utah, Ohio state university, and Washington University. Genevieve Melton-Meaux has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American medical informatics association. The institution of Genevieve Melton-Meaux has received research support from NIH, AHRQ, PCORI, FDA.
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Pramit Jagtap	Mr. Jagtap has nothing to disclose.
Maulik Lathiya, MBBS	Dr. Lathiya has nothing to disclose.
Karen S. Stalin	Ms. Stalin has nothing to disclose.
Santiago Martinez Sosa, MBBS	Dr. Martinez Sosa has nothing to disclose.
Jessica M. Besbris, MD	Dr. Besbris has nothing to disclose.
Roop Gursahani, MD, FAAN	Dr. Gursahani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for DR REDDY'S LABS.
Neha M. Kramer, MD	Dr. Kramer has nothing to disclose.
Sarah K. Bublitz, MD	Dr. Bublitz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ITF Pharma.
Mara Lugassy, MD	Dr. Lugassy has nothing to disclose.
John Y. Rhee, MD, MPH	Dr. Rhee has stock in NTAP. Dr. Rhee has stock in TSLA. Dr. Rhee has stock in BABA. Dr. Rhee has stock in ZM. Dr. Rhee has stock in GM. Dr. Rhee has stock in PFF. Dr. Rhee has stock in AMZN. Dr. Rhee has stock in META. Dr. Rhee has stock in GE. The institution of Dr. Rhee has received research support from ��ɫ��. Dr. Rhee has received personal compensation in the range of $0-$499 for serving as a Director of the Hippocratic Forum with Hippocratic Society.
Seema R. Rao, MBBS	Dr. Rao has nothing to disclose.
Krithika S. Rao, MD	The institution of Dr. Rao has received research support from Indian Council of Medical Research , New Delhi India.
Naveen Salins, MD, PhD	Dr. Salins has nothing to disclose.
Piret P. Paal, PhD	Dr. Paal has nothing to disclose.
Susan A. DeSanto-Madeya, PhD, RN	Dr. DeSanto-Madeya has nothing to disclose.
Soumya S. Pattnaik, PhD	Miss Pattnaik has nothing to disclose.
Sudhir C. Sarangi, MD, DM	The institution of Dr. Sarangi has received research support from Govt of India .
Yajnaseni Dash, Assistant Professor	Dr. Dash has nothing to disclose.
Manjari Tripathi, MD	Dr. Tripathi has nothing to disclose.
Ipshita Garg, MBBS	Dr. Garg has nothing to disclose.
Surabhi Ranjan, MD	Dr. Ranjan has nothing to disclose.
Nestor Galvez-Jimenez, MD	Dr. Galvez-Jimenez has nothing to disclose.
Katharine Dermigny, MD	Dr. Dermigny has nothing to disclose.
Christian Martin-Gill, MD	The institution of Dr. Martin-Gill has received research support from Pittsburgh Emergency Medicine Foundation. The institution of Dr. Martin-Gill has received research support from Department of Defense / US Army. The institution of Dr. Martin-Gill has received research support from National Institute of Health. The institution of Dr. Martin-Gill has received research support from Defense Advanced Research Projects Agency (DARPA). The institution of Dr. Martin-Gill has received research support from American Academy of Sleep Medicine (AASM) . The institution of Dr. Martin-Gill has received research support from Pediatric Pandemic Network (PPN) . The institution of Dr. Martin-Gill has received research support from American College of Medical Toxicology (ACMT).
Abdullah Sultany, MD	Dr. Sultany has nothing to disclose.
Francis X. Guyette, MD	The institution of Dr. Guyette has received research support from DoD.
Milagros Galecio-Castillo, MD	Dr. Galecio-Castillo has nothing to disclose.
Sophie L. Shogren, MD	Dr. Shogren has nothing to disclose.
Madelynne Olexa	Miss Olexa has nothing to disclose.
Leonardo Cruz, MD	Dr. Cruz has nothing to disclose.
Piyush Kalakoti, MBBS	Dr. Kalakoti has nothing to disclose.
Yelyzaveta Begunova	Miss Begunova has nothing to disclose.
Nils Petersen, MD	The institution of Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silkroad Medical. Dr. Petersen has received research support from NIH.
Santiago Ortega Gutierrez, MD	Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH. The institution of Dr. Ortega Gutierrez has received research support from PCORI.
Anderson Brito-Alvarado, MD	Dr. Brito-Alvarado has nothing to disclose.
Clayton W. Turner, DO	Mr. Turner has nothing to disclose.
Priyadharshine Ramesh Babu	Ms. Ramesh Babu has nothing to disclose.
Rebecca Ryznar, PhD	Dr. Ryznar has nothing to disclose.
Daniel S. Harrison, MD	Dr. Harrison has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Glass Health. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Diedrich & Donohue, LLP.
Christopher T. Doughty, MD	Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurometrix. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Doughty has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TD Securities. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Adler¦Cohen¦Harvey¦Wakeman¦Guekguezian, LLP. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gidley, Sarli & Marusak, LLP. Dr. Doughty has received research support from NINDS/NeuroNEXT. Dr. Doughty has received research support from AstraZeneca. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a Grant Advisory Board Member with Dysimmune Diseases Foundation. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with Oakstone Publishing.
Margaret Naclerio, PA	Ms. Naclerio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
Kathryn Swider	Dr. Swider has nothing to disclose.
Joel C. Morgenlander, MD, FAAN	Dr. Morgenlander has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Duke University.
Calli L. Cook, DNP, FNP-C, DAAN, FAAN	Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Deena Rodney	No disclosure on file
Shannon Anderson, PA, DAAN	Mrs. Anderson has nothing to disclose.
Megan S. Kennelly, RN, NP, DNP, MBA	Dr. Kennelly has nothing to disclose.
Elyse Doherty, PA	Ms. Doherty has nothing to disclose.
Cassie Meffert, PA	Ms. Meffert has nothing to disclose.
Alexander W. King, NP	Mr. King has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal.
Scott M. Friedenberg, MD, FAAN	The institution of Dr. Friedenberg has received research support from AMA. The institution of Dr. Friedenberg has received research support from Geisinger Medical Center.
Nathaniel M. Robbins, MD	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.
Ariel Nowicki	Ms. Nowicki has nothing to disclose.
Fnu Alfandy, DNP	Dr. Alfandy has nothing to disclose.
Kasser Saba, MD	Dr. Saba has nothing to disclose.
Pavan Vaswani, MD, PhD	Dr. Vaswani has received personal compensation in the range of $500-$4,999 for serving as a Travel/training support with Medtronic.
Allison Hennigan, MD	The institution of Dr. Hennigan has received research support from NIH .
Holly Bischof, RN, NP	Ms. Bischof has nothing to disclose.
Abigail M. Taylor, PA	Ms. Taylor has nothing to disclose.
Jason A. Johns, PA	Mr. Johns has nothing to disclose.
Shivani Ghoshal, MD	Dr. Ghoshal has nothing to disclose.
Alyssa Bautista, MD	Dr. Bautista has or had stock in Gravity Medical Technology.
John S. Emmett, PA	No disclosure on file
Shireen M. Jacob, MBBS	Dr. Jacob has nothing to disclose.
James McHenry, MD	Dr. McHenry has nothing to disclose.
Meghana Koleti, MD	Dr. Koleti has nothing to disclose.
Malvika Ramesh, MD	Dr. Ramesh has nothing to disclose.
Xiangping Li, MD, FAAN	Dr. Li has nothing to disclose.
Laura J. Wu, MD, PhD	Dr. Wu has nothing to disclose.
Kian Abdul-Baki, DO	Dr. Abdul-Baki has nothing to disclose.
Monica Juliana Ortiz-pereira, MD	Dr. Ortiz-pereira has nothing to disclose.
Natalia Gomez, MD	Ms. Gomez has nothing to disclose.
Eliana Pineda-Mateus, MD	Dr. Pineda-Mateus has nothing to disclose.
Fabio Suarez	Fabio Suarez has nothing to disclose.
Torge Rempe, MD	Dr. Rempe has nothing to disclose.
Mayra Montalvo Perero, MD	Dr. Montalvo Perero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG THERAPEUTICS. Dr. Montalvo Perero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN.
Danielle Tupes, NP	Mrs. Tupes has nothing to disclose.
Freddy Escobar-Montealegre, MD	Dr. Escobar-Montealegre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Elsa C. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Laura E. Snider, MD	Dr. Snider has nothing to disclose.
Paul Mystkowski, MD	Dr. Mystkowski has received personal compensation for serving as an employee of Novo Nordisk. Dr. Mystkowski has stock in Novo Nordisk.
Peter Johannsen, MD	Dr. Johannsen has received personal compensation for serving as an employee of Novo Nordisk. Dr. Johannsen has or had stock in Novo Nordisk.
Marie Bentsen	Marie Bentsen has received personal compensation for serving as an employee of Novo Nordisk.
Kate Attfield, MD, PhD	Dr. Attfield has nothing to disclose.
Kristian S. Frederiksen, MD, PhD	Dr. FREDERIKSEN has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer (Nature). Dr. FREDERIKSEN has received research support from AP Møller Fonden. Dr. FREDERIKSEN has received publishing royalties from a publication relating to health care.
Giovanni B. Frisoni	Dr. Frisoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Frisoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Frisoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. The institution of Dr. Frisoni has received research support from Novo Nordisk.
Rose Jeppesen, MD, PhD	Dr. Jeppesen has received personal compensation for serving as an employee of Novo Nordisk. Dr. Jeppesen has stock in Novo Nordisk.
Ibrahim Malik, MD, PhD	Dr. Malik has received personal compensation for serving as an employee of Novonordisk. Dr. Malik has stock in Novonordisk. Dr. Malik has received intellectual property interests from a discovery or technology relating to health care.
Lotte B. Knudsen, DMSc	Dr. Knudsen has stock in Novo Nordisk. Dr. Knudsen has received intellectual property interests from a discovery or technology relating to health care.
Beade Numbere, PhD	Dr. Numbere has received personal compensation for serving as an employee of UCB Pharma.
Herve Besson	Herve Besson has received personal compensation for serving as an employee of UCB.
Anna Kuba	Ms. Kuba has received personal compensation for serving as an employee of UCB.
Brian D. Moseley, MD	Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB.
Kristy L. Pucylowski, PharmD	Dr. Pucylowski has received personal compensation for serving as an employee of UCB, Inc.. Dr. Pucylowski has stock in UCB, Inc..
Allison Little, PharmD	Dr. Little has received personal compensation for serving as an employee of Rapport Therapeutics.
Dimitrios Bourikas	Dr. Bourikas has nothing to disclose.
Allison Leppke	Dr. Leppke has nothing to disclose.
Autherine Abiri, NP, DNP	Dr. Abiri has nothing to disclose.
Sandra Smieszek	Dr. Smieszek has received personal compensation for serving as an employee of Vanda Pharmaceuticals Inc.. Dr. Smieszek has stock in Vanda Pharmaceuticals Inc..
Bart Przychodzen	No disclosure on file
Christina Tyner	Christina Tyner has received personal compensation for serving as an employee of Vanda Pharmaceuticals Inc. Christina Tyner has or had stock in Vanda Pharmaceuticals Inc..
Caroline Johnson	Caroline Johnson has received personal compensation for serving as an employee of Vanda Pharmaceuticals, Inc.. Caroline Johnson has stock in Vanda Pharmaceuticals, Inc..
Christos Polymeropoulos	No disclosure on file
Gunther Birznieks	Gunther Birznieks has received personal compensation for serving as an employee of Vanda Pharmaceuticals. Gunther Birznieks has received intellectual property interests from a discovery or technology relating to health care.
David Hagan	David Hagan has received personal compensation for serving as an employee of Hesperos, Inc. David Hagan has stock in Hesperos, Inc.
Leticia Lenkiu	No disclosure on file
Caitlyn Niccum	Caitlyn Niccum has received personal compensation for serving as an employee of Hesperos.
Heather Cannon-Patron	Heather Cannon-Patron has received personal compensation for serving as an employee of Hesperos Inc.. Heather Cannon-Patron has stock in Hesperos Inc..
Rocky Brighton	Rocky Brighton has nothing to disclose.
Xiufang Guo	The institution of Xiufang Guo has received research support from NIH. The institution of Xiufang Guo has received research support from UCF/Office of Research & Comercialization/Florida High Tech Corridor Council (FHTCC) .
Kenneth Hawkins	No disclosure on file
Nesar Akanda	No disclosure on file
James Hickman	James Hickman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Hesperos, Inc.. James Hickman has stock in Hesperos, Inc.. The institution of James Hickman has received research support from Hesperos, Inc.. James Hickman has received intellectual property interests from a discovery or technology relating to health care. James Hickman has a non-compensated relationship as a Chief Scientist with Hesperos, Inc. that is relevant to AAN interests or activities.
Mihael Polymeropoulos	Mihael Polymeropoulos has received personal compensation for serving as an employee of Vanda Pharmaceuticals . Mihael Polymeropoulos has received personal compensation for serving as an employee of Vanda Pharmaceuticals . Mihael Polymeropoulos has stock in Vanda Pharmaceuticals .
Marcos Arreola Flores, MD	Dr. Arreola Flores has nothing to disclose.
Yahir A. Chico-Alcaraz, MD	Mr. Chico-Alcaraz has nothing to disclose.
María F. Aguilar López	Miss Aguilar López has nothing to disclose.
José Miguel Perales Vaquera	Mr. Perales Vaquera has nothing to disclose.
Miguel A. Solis Lecuona, MD	Dr. Solis Lecuona has nothing to disclose.
Thania F. Estrada Ortega	Miss Estrada Ortega has nothing to disclose.
Oziel Gonzalez Godoy, Jr., MBBS	Dr. Gonzalez Godoy has nothing to disclose.
Luis J. Hernandez Rangel, Medical Student	Mr. Hernandez Rangel has nothing to disclose.
David Jeshua Resendiz Daniel, MD	Dr. Resendiz Daniel has nothing to disclose.
Emma de la Salud Pahua Mota, MPSS	Miss Pahua Mota has nothing to disclose.
Karla Guevara, Student	Miss Guevara has nothing to disclose.
Angel G. Martinez Hernandez, Sr., MD	Mr. Martinez Hernandez has nothing to disclose.
Sara L. Gomez, MBBS	Miss GOMEZ has nothing to disclose.
Ahmed M. Shaheen	Dr. Shaheen has a non-compensated relationship as a A Research Position Candidate Under Trial Task with Solvemed Company that is relevant to AAN interests or activities.
Ram K. Saha, MD	Dr. Saha has nothing to disclose.
Nour Shaheen, Sr., MBBS	Mr. Shaheen has nothing to disclose.
Wail Abdelhamid Amroune, MD	Mr. Amroune has nothing to disclose.
Howard Feldman, MD, FAAN	The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Philip Scheltens, MD, PhD, FAAN	Dr. Scheltens has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NOrdisk.
Oskar Hansson	Oskar Hansson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for from Alzpath, BioArctic, Biogen, Bristol Meyer Squibb, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. Oskar Hansson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for from Alzpath, BioArctic, Biogen, Bristol Meyer Squibb, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. Oskar Hansson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for from Alzpath, BioArctic, Biogen, Bristol Meyer Squibb, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. The institution of Oskar Hansson has received research support from AVID Radiopharmaceuticals, Biogen, C2N Diagnostics, Eli Lilly, Eisai, Fujirebio, GE Healthcare, and Roche.
Mary Sano, PhD	Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Avenir. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for BioXcel. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for CogRx. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for F. Hoffman LaRoche. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Minerva Neuroscience. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoNordisk. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Pfizer. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for vTv Therapeutics. Dr. Sano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's Association. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Psychogeriatric Association.
Wiesje van der Flier, PhD	The institution of Prof. van der Flier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Prof. van der Flier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. The institution of Prof. van der Flier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. The institution of Prof. van der Flier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. The institution of Prof. van der Flier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Lars Bardtrum, MSc	Mr. Bardtrum has received personal compensation for serving as an employee of Novo Nordisk A/S. Mr. Bardtrum has stock in Novo Nordisk A/S.
Teresa Leon, MD, PhD	Dr. Leon has received personal compensation for serving as an employee of Novo Nordisk A/S Copenhagen. Dr. Leon has stock in Novo Nordisk. Dr. Leon has stock in Pharma Mar.
Charlotte Thim Hansen	Charlotte Thim Hansen has received personal compensation for serving as an employee of Novo Nordisk A/S.
Jeffrey L. Cummings, MD, FAAN	Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Yohan Kim, DO	Dr. Kim has nothing to disclose.
Sidarrth Prasad, MBBS	Sidarrth Prasad has nothing to disclose.
DaiWai Olson	The institution of DaiWai Olson has received research support from Neuroptics. The institution of DaiWai Olson has received research support from Chiesi.
Mehari Gebreyohanns, MD, FAAN	Dr. Gebreyohanns has nothing to disclose.
Suzanne Stone	Suzanne Stone has nothing to disclose.
Nneka L. Ifejika, MD	Dr. Ifejika has nothing to disclose.
Erica M. Jones, MD, MPH	The institution of Dr. Jones has received research support from NIH KL2.
Kim Barker, MD	Dr. Barker has nothing to disclose.
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Steven Warach, MD, PhD	Dr. Warach has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Warach has received research support from State of Texas. Dr. Warach has received publishing royalties from a publication relating to health care.
Mark P. Goldberg, MD	The institution of Dr. Goldberg has received research support from NIH. The institution of Dr. Goldberg has received research support from State of Texas .
Steven J. Roman Troche, MD	Dr. Roman Troche has nothing to disclose.
Francine L. Tait, MD	Dr. Tait has nothing to disclose.
Bianca M. Lopez, MD	Dr. Lopez has nothing to disclose.
Vaishnavi Aryapadi, MD	Dr. Aryapadi has nothing to disclose.
Lauren Tardo, MD	Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NeurologyLive. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a consultant with CanDoMS. Dr. Tardo has a non-compensated relationship as a Tardo with The MOG Project that is relevant to AAN interests or activities.
Kyle M. Blackburn, MD	Dr. Blackburn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx.
Shaida Khan, DO	Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Group instructor with Real CME.
Amber Salter, PhD	Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Diana Noland, Registered Dietitian	Mrs. Noland has nothing to disclose.
Rhett Bergeron, MD	Dr. Bergeron has nothing to disclose.
Larisa Syrow, MD	Dr. Syrow has nothing to disclose.
Rachel B. Green, MD	Dr. Green has nothing to disclose.
Nicholas Mallett, MD	Dr. Mallett has nothing to disclose.
Christopher D. Lee, MD	Dr. Lee has nothing to disclose.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Chenyue Zhao, PhD	Dr. Zhao has received personal compensation for serving as an employee of Eisai Inc.. Dr. Zhao has received personal compensation for serving as an employee of Novo Nordisk Inc.. An immediate family member of Dr. Zhao has received personal compensation for serving as an employee of Bicycle Therapeutics .
Malena Mahendran	The institution of Mrs. Mahendran has received research support from Eisai Inc.
Se Ryeong Jang, MPH	Miss Jang has received personal compensation for serving as an employee of Eisai Inc.
Francois Laliberte	Mr. Laliberte has received personal compensation for serving as an employee of Analysis Group.
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Kaixin Zhang	The institution of Ms. Zhang has received research support from Eisai Inc..
Feride H. Frech, PhD	Dr. Frech has received personal compensation for serving as an employee of Eisai Inc.
Mohamed Derhab, MD, MBBCH	Dr. Derhab has nothing to disclose.
Omar Elmandouh, MD	Dr. Elmandouh has nothing to disclose.
Abdelrahman Hamouda, MD	Dr. Hamouda has nothing to disclose.
Mark Cwajna, MD	Dr. Cwajna has nothing to disclose.
Nicholas J. Kendall, Medical Student	Mr. Kendall has nothing to disclose.
David Kallmes, MD	Dr. Kallmes has stock in Nested Knowledge. Dr. Kallmes has stock in Piraeus Medical. Dr. Kallmes has stock in Conway Medical. Dr. Kallmes has stock in Superior Medical Experts.
Sherief Ghozy	Mr. Ghozy has nothing to disclose.
Ahmad S. Ali, MD	Dr. Ali has nothing to disclose.
Galina Gheihman, MD	Dr. Gheihman has nothing to disclose.
Tamara B. Kaplan, MD, FAAN	Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono . Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Jinpyo Hong	Mr. Hong has nothing to disclose.
Alexander Haddad	No disclosure on file
Manish Aghi, MD, PhD	Dr. Aghi has nothing to disclose.
Isabella Lovalvo, BS	Ms. Lovalvo has nothing to disclose.
Meeki Lad, MPH	Mr. Lad has nothing to disclose.
Joyce A. Jimenez Zambrano, MD	Dr. Jimenez Zambrano has nothing to disclose.
Jake Plagenz, MD	Jake Plagenz, MD has nothing to disclose.
Cody A. Boyle, PhD	Mr. Boyle has nothing to disclose.
Sydney Bitting	Miss Bitting has nothing to disclose.
Amy K. Tao	Ms. Tao has nothing to disclose.
Erin Friel	Miss Friel has nothing to disclose.
Jasmin Rivero-Guerra, Student-Worker	Ms. Rivero-Guerra has nothing to disclose.
Davis C. Hobley	Mr. Hobley has nothing to disclose.
Rachel Batchelor	Miss Batchelor has nothing to disclose.
Shria Ajay	Ms. Ajay has nothing to disclose.
Athena Alexynne M. Apaga	Miss Apaga has nothing to disclose.
Daniel Choi	Mr. Choi has nothing to disclose.
Rebekah Y. Choi	Miss Choi has nothing to disclose.
Gabriela I. De Jesus, College Student	Ms. De Jesus has nothing to disclose.
Larry Ejiofor	Mr. Ejiofor has nothing to disclose.
Judy Y. Gao, AB (in progress)	Miss Gao has nothing to disclose.
Jasmine Hao	Miss Hao has nothing to disclose.
Daniel H. Kim	Mr. Kim has nothing to disclose.
Angelica Lappay	Miss Lappay has nothing to disclose.
Zaighum Nagra	Mr. Nagra has nothing to disclose.
Trixie Okoye	Ms. Okoye has nothing to disclose.
Aarane Ratnaseelan	Ms. Ratnaseelan has nothing to disclose.
Chloe Riche	Ms. Riche has nothing to disclose.
Karina Saba	Ms. Saba has nothing to disclose.
Diana Stinkova, Bachelor's Degree of Science	Ms. Stinkova has nothing to disclose.
Kathleen Tang	Miss Tang has nothing to disclose.
Emily Yeow	Ms. Yeow has nothing to disclose.
Maya I. Ragavan	The institution of Dr. Ragavan has received research support from National Institutes of Health .
Christina Briscoe Abath, MD	The institution of Dr. Briscoe Abath has received research support from Harvard Medical School. Dr. Briscoe Abath has a non-compensated relationship as a Board of Trustees Member with Brother's Brother Foundation that is relevant to AAN interests or activities. Dr. Briscoe Abath has a non-compensated relationship as a Professional Advisory Board with Epilepsy Foundation that is relevant to AAN interests or activities.
Laura A. Kirkpatrick, MD	The institution of Dr. Kirkpatrick has received research support from American Epilepsy Society. The institution of Dr. Kirkpatrick has received research support from Child Neurologist Career Development Program. The institution of Dr. Kirkpatrick has received research support from Child Neurology Foundation. The institution of Dr. Kirkpatrick has received research support from Rosenau Family Research Foundation. The institution of Dr. Kirkpatrick has received research support from Society of Family Planning. The institution of Dr. Kirkpatrick has received research support from Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with One8 Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with Brigham and Women's Hospital. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Meeting Attendee with Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with Society of Family Planning. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Norton Children's Hospital. Dr. Kirkpatrick has a non-compensated relationship as a Board of Directors member with My Epilepsy Story that is relevant to AAN interests or activities.
Jason Lu	Mr. Lu has nothing to disclose.
Selena Y. Xiang	Ms. Xiang has nothing to disclose.
Luiza Weissmann	Ms. Weissmann has nothing to disclose.
Bishow Chandra C. Mahat, MD	Dr. Mahat has nothing to disclose.
Vanessa Dwairi, MD	Dr. Dwairi has nothing to disclose.
Lamees Alhallaq, MD	Dr. Alhallaq has nothing to disclose.
Madeline Williamson, MS, CGC	Mrs. Williamson has nothing to disclose.
Andrés F. Patiño-Aldana, MD, MSc	Dr. Patiño-Aldana has nothing to disclose.
Valeria Florez, MD	Dr. Florez has nothing to disclose.
Paula F. Delgado Rosero, Resident	Dr. Delgado Rosero has nothing to disclose.
Natalia Rueda, MD	Dr. Rueda has nothing to disclose.
Rodrigo PARDO TURRIAGO, MD	Prof. PARDO TURRIAGO has nothing to disclose.
DANIELA SANCHEZ SANTIESTEBAN, MD	Dr. SANCHEZ SANTIESTEBAN has nothing to disclose.
Mohammad R. Ghani, MD	Dr. Ghani has nothing to disclose.
Rebecca Lightman	Miss Lightman has nothing to disclose.
Martin E. Brown, MD	Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with University of Louisville.
Delia Sam	An immediate family member of Dr. Sam has received personal compensation for serving as an employee of Mind Computing. Dr. Sam has stock in Netflix and Apple.
Jessica Bloom, MD	Dr. Bloom has nothing to disclose.
Dominic A. Ferrey, MD	Dr. Ferrey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca.
Bruna Leles Vieira de Souza, MD	Miss Leles Vieira de Souza has nothing to disclose.
Joao Vitor Mahler, MD	Dr. Mahler has received research support from The Sumaira Foundation.
Marcelo Matiello, MD, FAAN	Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer.
Marinos G. Sotiropoulos, MD	Dr. Sotiropoulos has or had stock in Moderna.Dr. Sotiropoulos has or had stock in Ikena Oncology.Dr. Sotiropoulos has or had stock in Cassava Sciences.Dr. Sotiropoulos has or had stock in Biogen.Dr. Sotiropoulos has or had stock in Tiziana Life Sciences.Dr. Sotiropoulos has received publishing royalties from a publication relating to health care.
Jose A. Stuchi, PhD	Dr. Stuchi has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Phelcom Technologies. Dr. Stuchi has stock in Phelcom Technologies.
Marissa Ilardi, MD	Dr. Ilardi has nothing to disclose.
Patrick M. Kwon, MD	Dr. Kwon has nothing to disclose.
Jessica H. Goldstein, MD, FAAN	Dr. Goldstein has nothing to disclose.
Jeffrey Strelzik, MD	Dr. Strelzik has nothing to disclose.
Kathryn L. Xixis, MD	Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Neurology Committee Member to ACGME-ABMS Symposium on CBME (hotel and travel expenses) with ACGME. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Child Neurology Representative to ABPN Critical Issues Forum (on CBME) (hotel and travel expenses) with ABPN. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker (Honorarium) with Oklahoma State Graduate Medical ��ɫ�� Committee. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a AAN ��ɫ�� Committee Member (hotel and travel expenses) with AAN. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a UCNS Accreditation Council (hotel and travel expenses) with UCNS. Dr. Xixis has a non-compensated relationship as a Podcast Writer and Editor of CNS Podcast Brainstorm with Child Neurology Society that is relevant to AAN interests or activities.
Jaclyn Martindale, DO, FAAN	Dr. Martindale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Dr. Martindale has received research support from Tourette Association of America. The institution of Dr. Martindale has received research support from American Board of Neurology and Psychiatry.
Abhilash Velaga, MBBS	Mr. Velaga has nothing to disclose.
Avin Aphrodite Babakhani, MD, PhD	Dr. Babakhani has nothing to disclose.
Natalie Erickson	Miss Erickson has nothing to disclose.
Andrew Sefain, MD	Dr. Sefain has nothing to disclose.
Rebecca Caillier, MD	Dr. Caillier has received personal compensation in the range of $100,000-$499,999 for serving as a Physician employee with Fargo VA.
Bavica Gummadi, DO	Dr. Gummadi has nothing to disclose.
Joanna Marmo	Joanna Marmo has nothing to disclose.
Laura M. Ades, MD	Dr. Ades has nothing to disclose.
Aaron Lord, MD	Dr. Lord has nothing to disclose.
Fatma Yesim Parman, MD	Dr. Parman has nothing to disclose.
Arman Cakar	No disclosure on file
Ayse Candayan	Ayse Candayan has nothing to disclose.
GULANDAM BAGIROVA, PhD candidate	Mrs. BAGIROVA has nothing to disclose.
Zehra O. Uyguner, PhD	Prof. Uyguner has nothing to disclose.
Serdar Ceylaner	Serdar Ceylaner has nothing to disclose.
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Esra Battaloglu	Esra Battaloglu has nothing to disclose.
Emily Unebasami	Miss Unebasami has nothing to disclose.
J. Douglas Miles, MD, PhD, FAAN	Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
Gabrielle Dufort, MD	Dr. Dufort has nothing to disclose.
Jacinda B. Sampson, MD, PhD	Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Devon Bonner, ScM	The institution of Ms. Bonner has received research support from National Institutes of Health.
Beatriz Anguiano, MS	Miss Anguiano has nothing to disclose.
Jon Bernstein, MD, PhD	Dr. Bernstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Bernstein has received research support from NIH.
Matthew T. Wheeler, MD, PhD	Dr. Wheeler has stock in Personalis. The institution of Dr. Wheeler has received research support from BMS. The institution of Dr. Wheeler has received research support from Pfizer. The institution of Dr. Wheeler has received research support from Salubris Bio. The institution of Dr. Wheeler has received research support from Cytokinetics. The institution of Dr. Wheeler has received research support from Nihon Koden. The institution of Dr. Wheeler has received research support from Alexion.
Haelynn Gim	Miss Gim has nothing to disclose.
Benjamin Cook	Mr. Cook has nothing to disclose.
Jasmin Le, MBBS	Ms. Le has nothing to disclose.
Christina Guo, MD	Dr. Guo has nothing to disclose.
Brandon Stretton, MBBS	Dr. Stretton has nothing to disclose.
Stephen Bacchi, MBBS	Dr. Bacchi has nothing to disclose.
Matthew Arnold, MBBS, MClinEd	Dr. Arnold has a non-compensated relationship as a Director of the Board with Adelaide Medical Students' Foundation (non-profit organization) that is relevant to AAN interests or activities.
Juliana Stoilova, MD	Ms. Stoilova has nothing to disclose.
Kenneth P. Martinez, MD	The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. The institution of Dr. Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Martinez has received research support from Medtronic. The institution of Dr. Martinez has received research support from Abbvie/Allergan.
Michele Potashman, PhD	Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Basia Rogula	Basia Rogula has received personal compensation for serving as an employee of Broadstreet HEOR.
Lauren Powell	Lauren Powell has nothing to disclose.
Ellen Korol	Ellen Korol has received personal compensation for serving as an employee of Broadstreet HEOR.
Samuel Dickson	Mr. Dickson has nothing to disclose.
Suzanne Hendrix, PhD	Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Maggie Heinrich	Maggie Heinrich has received personal compensation for serving as an employee of Parexel.
Katja Rudell	No disclosure on file
Linda Abetz Webb	The institution of Linda Abetz Webb has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Parexel.
Melissa Beiner	Melissa Beiner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Melissa Beiner has stock in Biohaven Pharmaceuticals.
Vlad Coric	No disclosure on file
Liana Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Pharmaceuticals. Dr. Rosenthal has received research support from NIH. Dr. Rosenthal has received research support from Gordon and Marilyn Macklin Foundation. Dr. Rosenthal has received research support from The Daniel B. and Florence E. Green Foundation. Dr. Rosenthal has received research support from National Ataxia Foundation. Dr. Rosenthal has received research support from Michael J. Fox Foundation. Dr. Rosenthal has received research support from Pfizer. Dr. Rosenthal has received research support from Biohaven Pharmaceuticals. Dr. Rosenthal has a non-compensated relationship as a Medical Director, ex-officio Member of the Board with National Ataxia Foundation that is relevant to AAN interests or activities.
Susan L. Perlman, MD	Dr. Perlman has nothing to disclose.
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Brendan Putko, MD, MSc	Dr. Putko has nothing to disclose.
Eric J. Sorenson, MD, FAAN	The institution of Dr. Sorenson has received research support from Biogen.
Teerin Liewluck, MD, FAAN	Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Ava Siegel	Ms. Siegel has nothing to disclose.
Daniel A. Almstead	Mr. Almstead has nothing to disclose.
Naveen Kothandaraman	Mr. Kothandaraman has nothing to disclose.
Erica Lamkin, Student	Miss Lamkin has nothing to disclose.
Kanayo E. Ikeh, PhD	Dr. Ikeh has nothing to disclose.
Andrew Crompton	Mr. Crompton has nothing to disclose.
Hannah Koval	Miss Koval has nothing to disclose.
Jessica Reich, Undergraduate	Miss Reich has nothing to disclose.
Roxana del Rio Guerra	Dr. del Rio Guerra has nothing to disclose.
Dmitry M. Korzhnev, PhD	The institution of Prof. Korzhnev has received research support from NIH.
Kyle Hadden, PhD	Dr. Hadden has nothing to disclose.
Jiyong Hong, PhD	Prof. Hong has nothing to disclose.
Pei Zhou, PhD	Dr. Zhou has nothing to disclose.
Nimrat Chatterjee, PhD	Dr. Chatterjee has received research support from Nih.
Lindsay P. Allen	Miss Allen has nothing to disclose.
Fahad S. Bahanan, MBBS	Dr. Bahanan has nothing to disclose.
Ali Mohammed Alshehri, MD	Dr. Alshehri has nothing to disclose.
Alanood A. Alsolaihim, MD, MBBS	Dr. Alsolaihim has nothing to disclose.
Mossaed Alyahya, MD	Dr. Alyahya has nothing to disclose.
AFAF ALSAGHEIR, MBBS	Dr. ALSAGHEIR has nothing to disclose.
Muteb M. Aldawsari, MD	Dr. Aldawsari has nothing to disclose.
Sarah S. Almanea, Epidemiologists	Miss Almanea has nothing to disclose.
Julius B. Anang, MD, FAAN	The institution of Dr. Anang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Anang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan.
Nan Jiang, MD	Dr. Jiang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for • Amylyx . Dr. Jiang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen .
Marla B. Morgan, MD	Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Wendy Everett, ScD	Dr. Everett has a non-compensated relationship as a Advisor with Institute for Clinical and Economic Research that is relevant to AAN interests or activities.
Adrian Kielhorn	Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion.
Kelly McNeil-Posey, RN	Mrs. McNeil-Posey has received personal compensation for serving as an employee of Alexion Pharma.
Stacey Tatroe, NP	Ms. Tatroe has nothing to disclose.
Kristi R. Mitchell, MPH	Ms. Mitchell has nothing to disclose.
Sheila K. Fifer, PhD	Ms. Fifer has nothing to disclose.
Pravin Khemani, MD, FAAN	Dr. Khemani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cala Trio. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Boyang Bian	Boyang Bian has received personal compensation for serving as an employee of Biogen. Boyang Bian has stock in Biogen.
Daniel Gomes	Mr. Gomes has received personal compensation for serving as an employee of Voxanalytica. Mr. Gomes has stock in Biogen. Mr. Gomes has stock in Roche. Mr. Gomes has stock in Novartis. Mr. Gomes has stock in Merck & Co. Inc.. Mr. Gomes has stock in Pfizer. Mr. Gomes has stock in Eli Lilly. The institution of Mr. Gomes has received research support from Biogen.
Sarah England, PhD	Dr. England has received personal compensation for serving as an employee of Biogen. Dr. England has stock in Biogen.
Jim McKay, PhD	Dr. McKay has received personal compensation for serving as an employee of Biogen. Dr. McKay has stock in Biogen.
Tony Wang, PhD	Dr. Wang has nothing to disclose.
Shakti Nayar, MD	Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Robin L. Avila, PhD	Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
ZIYI YANG, MASTER	Ms. YANG has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Voxanalytica.
Lesley-Ann 9. Miller-Wilson, PhD	Dr. Miller-Wilson has received personal compensation for serving as an employee of Immunovant Inc. Dr. Miller-Wilson has or had stock in Immunovant Inc..
Lincy Lal, PhD	Mrs. Lal has received personal compensation for serving as an employee of Immunovant. Mrs. Lal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with UT School of Public Health.
Joe Conyers	Mr. Conyers has nothing to disclose.
Shiva L. Birija, BSc	Miss Birija has nothing to disclose.
Ciara Ringland	Miss Ringland has nothing to disclose.
Hannah Connolly	Hannah Connolly has nothing to disclose.
Gregor Gibson	Mr. Gibson has nothing to disclose.
NIALL HATCHELL	Mr. HATCHELL has nothing to disclose.
Yuriy Edwards, MD, PhD	Dr. Edwards has received personal compensation for serving as an employee of Immunovant. Dr. Edwards has stock in Immunovant.
Michela Myriam De Maio, Medical Student	Mrs. De Maio has nothing to disclose.
Federico Habetswallner, MD, RN	Dr. Habetswallner has nothing to disclose.
Eleonora Sabatelli	Eleonora Sabatelli has nothing to disclose.
Gregorio Spagni	Gregorio Spagni has nothing to disclose.
Amelia Evoli, MD	Prof. Evoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Prof. Evoli has received personal compensation in the range of $500-$4,999 for serving as a jury member for research grant with Grifols. Prof. Evoli has received personal compensation in the range of $500-$4,999 for serving as a speaker with UCB.
Jiawei Wang, MD, PhD	Dr. Wang has nothing to disclose.
Nara Michaelson, MD	The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS). Dr. Michaelson has received research support from Sanofi.
Julia Greenberg, MD	Dr. Greenberg has a non-compensated relationship as a Editorial Board Member with Neurology Resident and Fellow Section that is relevant to AAN interests or activities.
Ashley M. Bach, MD MPH	Dr. Bach has nothing to disclose.
Skyler Kane	Ms. Kane has nothing to disclose.
Ariel M. Lyons-Warren, MD, PhD	Dr. Lyons-Warren has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Lyons-Warren has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Whitley W. Aamodt, MD	Dr. Aamodt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Brooke Eikenberry	Ms. Eikenberry has received personal compensation for serving as an employee of ��ɫ��. An immediate family member of Ms. Eikenberry has received personal compensation for serving as an employee of Supernus Pharmaceuticals. An immediate family member of Ms. Eikenberry has stock in Supernus Pharmaceuticals.
Júlia N. Andrade	Mrs. Andrade has nothing to disclose.
Luis H. Soares Silva	Mr. Soares Silva has nothing to disclose.
Jennifer V. Da Silva Bentes, MS	Miss Da Silva Bentes has nothing to disclose.
Antônio Victor Cavalcanti Araújo, MS	Mr. Araújo has nothing to disclose.
Maria Luiza Lima Schneider, MS	Miss Lima Schneider has nothing to disclose.
Fernanda M. Tamashiro	Miss Tamashiro has nothing to disclose.
Luis Sobreira, MS	Mr. Sobreira has nothing to disclose.
Laurel J. Cherian, MD, FAAN	The institution of Dr. Cherian has received research support from NIH.
Moon H. Lee	Moon H. Lee has nothing to disclose.
Kaori Kawaguchi	The institution of Kaori Kawaguchi has received research support from the Ministry of ��ɫ��, Culture, Sports, Science and Technology of Japan (MEXT).
Omar Anani	Omar Anani has nothing to disclose.
Muhammad Sohaib, MBBS	Mr. Sohaib has nothing to disclose.
Abdul Jaber Tayem, MD	Dr. Tayem has nothing to disclose.
Nika Bejou, PharmD	Dr. Bejou has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Louis Ferrari	Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Grant T. Corbett, PhD	Dr. Corbett has received personal compensation for serving as an employee of Novo Nordisk Inc.. Dr. Corbett has stock in Novo Nordisk Inc.
Carlos Guevara Oliva, MD	Dr. Guevara Oliva has nothing to disclose.
Julia Mello, Student	Mrs. Mello has nothing to disclose.
Steven T. Whitworth, PhD	Dr. Whitworth has received personal compensation for serving as an employee of Neurelis Inc..
Rachael Wittmer	Miss Wittmer has nothing to disclose.
Sai Varun Bethina, MBBS	Dr. Bethina has nothing to disclose.
Zeng Y. Wang, MD, PhD, FAAN	Dr. Wang has nothing to disclose.
Roberta Messina, MD, PhD	Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly.
Rolando M. Cordoves-Feria, MD	No disclosure on file
Jim McKay, PhD	Dr. McKay has received personal compensation for serving as an employee of Biogen. Dr. McKay has or had stock in Biogen.
Sarika Mutyala, MBBS	Dr. Mutyala has nothing to disclose.
Michael Devlin	Mr. Devlin has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for The Sumaira Foundation.
Yugant Khand, MBBS, DiMM	Dr. Khand has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��